{"docstore/metadata": {"59fbecda-6156-4f58-a7c7-22664ae007d6": {"doc_hash": "bcc78ca0352a10338a62ac80924dbd5a61c66ebc2f5397b22525ae97c6e93b46"}, "25cec983-7e0c-4f6e-80d7-91bc7d77de2d": {"doc_hash": "8b9c68adb1e717294fdde1a55f87c4bf06a8801e35d5b8b5b674ee1bf04d1fb4"}, "6cf2ecc2-6aaf-474b-ac39-51d09571ba7a": {"doc_hash": "02e0b0f559488f8b7acac2fabe2e4a70afd7349ab4b5df553279f77920d8179e"}, "fca7c5d1-758d-4241-89b4-eb2967a7ab39": {"doc_hash": "5675940d0befe54154250f81ca90037a0e151d6bd50c58fba236a8461d76431d"}, "f7e729ac-6e8b-4149-b301-941074f48622": {"doc_hash": "d2f516d71484fdd89e31b38214b87fa313972311ccdc084bbd910b34b269abe7"}, "b82e9f3c-09d4-4226-878f-f98c664a83c9": {"doc_hash": "e9a3218a7da7e59cbfd11de35754ed239a56da1f5ea1c5953c9c8883d5b74c28"}, "98cc6f61-4959-47d8-9b52-9d9113037a59": {"doc_hash": "3f3c160c314120a28a721bd1982ce23d3fdbe6960714be54542cd10c5e9c1665"}, "e8b7c9e8-6645-4aec-8f45-f4dd18e35dff": {"doc_hash": "fe9a3ad3387ca1e71f2d40f5980f350a3e537bc5ce12ec670b6351f3296c20cf"}, "8b42b374-4b68-48dd-81e2-66429f31a7e9": {"doc_hash": "6fc904473cd4bd4fe9c4e15619fc6856f4f45556f9b29e3630ff2f53217458d4"}, "0260d65c-88d7-40f2-9dea-c7f2c0641e19": {"doc_hash": "9b94fd0d4038bf484c7f268691667eeddc3fb40864c7e19c721a4c5f977488cf"}, "52b6b13f-0153-47f6-bf11-94cc62c72001": {"doc_hash": "1e27535f0395f964a1b04d113be5a61fa3b69f5da1ecfc64dd6b2bd953ee4b9a"}, "6e4fefb9-005a-4784-ae24-29ad4358f53a": {"doc_hash": "4e7518a69a125647003cbf7ef6d71c24d99ae750cce7f09423463b13e05a99c7"}, "26c53517-9bf4-40c1-a7f0-9be5fc0cae1d": {"doc_hash": "d4ef05b919b0ab08628888daf9ac95d16a02b05db8f8887813a1267f4c16d8fe"}, "2e6569f8-ea8b-449b-b85e-d8e3ed7a2548": {"doc_hash": "f39bdebe5bf66b262ae7c05901c58992a3ffa24c193c3fe97241987679e78dd3"}, "00501aa2-e3bc-4bc5-a0f8-2514db95ae56": {"doc_hash": "f91cde520f3e90bc1e38a202c24606f0a400f08940a5cbad0ae440efa16af779"}, "dd82ef3b-362f-429f-94ed-78b4d02e9b73": {"doc_hash": "f85d0e6381ddc02274955320324b1668954fc668e63999dbc1c17ff2b3cd1b68"}, "44689381-06a7-41a8-b39b-b7f61185ffaf": {"doc_hash": "f8128d7c90f250485c849b456799e7f1903234561671b7be50b66eab72a63f3a"}, "80d027b1-4e89-4290-92b5-5cd5bc479f0f": {"doc_hash": "221f7494d55116da6adb0fc4b47d404b3acf24277d811fa248748439dc1b863d"}, "790ac20b-1cac-4e60-aed0-10b7a37f3ab2": {"doc_hash": "9ec4180eb9884336ac1c999f1901164238a6c3d95dc23ba0e81440eaf523adce"}, "4844296c-c520-442e-83e1-03e996168065": {"doc_hash": "070a0363f3d1441c57442ac3961166df69fff57c0fc2f4dbef7912061c553969"}, "40d7ae4f-be1e-4932-a65a-a16b93fd20d9": {"doc_hash": "178b671ccbd7d5c888f15e063eea8c7a0e5e13e4c751e9db5d5651fb9ecb9239"}, "ca105563-483d-40fe-80f1-6f6f756a34bf": {"doc_hash": "bcc78ca0352a10338a62ac80924dbd5a61c66ebc2f5397b22525ae97c6e93b46", "ref_doc_id": "59fbecda-6156-4f58-a7c7-22664ae007d6"}, "b4f9d316-86ec-4b5d-a537-19ea4959f52f": {"doc_hash": "8b9c68adb1e717294fdde1a55f87c4bf06a8801e35d5b8b5b674ee1bf04d1fb4", "ref_doc_id": "25cec983-7e0c-4f6e-80d7-91bc7d77de2d"}, "c71ad92a-e708-4900-8774-85d47de4f308": {"doc_hash": "e0a220f7e88102a60bb189d8e876575df02fb0c03fd60be623bbb2ec4783bfa7", "ref_doc_id": "6cf2ecc2-6aaf-474b-ac39-51d09571ba7a"}, "6501bc42-c37b-4bec-be37-a8dff4869c9a": {"doc_hash": "5c606d5a2239023790448b41c791755847775069ce51b183721c5d9cb3094f9a", "ref_doc_id": "6cf2ecc2-6aaf-474b-ac39-51d09571ba7a"}, "1658a190-c1b2-48ba-90aa-cdfce6409f0d": {"doc_hash": "cebb124f5f6adbca3ea6a976d6d3d6a65e649cc721aad7e966fa111d79bbfc44", "ref_doc_id": "fca7c5d1-758d-4241-89b4-eb2967a7ab39"}, "81702a86-f4d2-408d-baf7-a7c685ce62cb": {"doc_hash": "77978ca3e47bacd1855c4ce695eeedd6eff847cccbd2d1dfacfb300998c8a6d7", "ref_doc_id": "fca7c5d1-758d-4241-89b4-eb2967a7ab39"}, "cda50a1e-e7f1-440b-9c51-ed6a5acc1303": {"doc_hash": "d2f516d71484fdd89e31b38214b87fa313972311ccdc084bbd910b34b269abe7", "ref_doc_id": "f7e729ac-6e8b-4149-b301-941074f48622"}, "260be4ec-081c-407f-9b7d-64b81fe3d8d7": {"doc_hash": "6182870e86de978f86ab4c4ad1b259df80353598f9122f0a6f55628c865afbc4", "ref_doc_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9"}, "09082eeb-ed0b-4072-9e4c-8342673fee84": {"doc_hash": "1e982ab56952d2facd25d3d7cc0ffd97b902e28419ac4c2fd8e7238528587aab", "ref_doc_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9"}, "c4855293-ab9e-4763-bdc9-d092b9c68e9c": {"doc_hash": "53540a06482d670141571bf241813fcad3cd2252b0482c1ea3fcb1319395a11c", "ref_doc_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9"}, "5dff48db-0ec0-46c9-837a-a535a58749a3": {"doc_hash": "d9db2610a03aa3e0453630433e2aeb739b9325b59653777bad3d28c91679be8d", "ref_doc_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9"}, "9869ce23-1379-43e3-bb66-ce51ccf7d09d": {"doc_hash": "23b569ddd2e04f225dac7e372982737362091facea349a0336c711bff49569f2", "ref_doc_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9"}, "82ff1241-dd62-41b2-9748-082f33895ac3": {"doc_hash": "2fcb2ef03f9da38609dea4f7756e18ab43cab74faa84a08c6de1c84435de70e4", "ref_doc_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9"}, "06bee9fa-1f69-45a2-80d0-e51596471aed": {"doc_hash": "35ffa4adf8f2c869685cfcb4a105fe39eb874cac9837a1373c865c4670ffb43a", "ref_doc_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9"}, "ae6f91f4-9c2f-4427-9a28-1e6f429df9aa": {"doc_hash": "00c3798c7a6d7898d74aadc15e0b2b39aa6858e75510a6f28adeca8d15fc6bf4", "ref_doc_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9"}, "99fc276a-9d80-4b50-9d4c-f5eff661bd8f": {"doc_hash": "857810b5b766b6bc5b0711cd184fc6feedb5f52b7522db4c40b6064b0827667b", "ref_doc_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9"}, "2ae79675-0c62-43a3-b248-c8bfed8c7b74": {"doc_hash": "3f3c160c314120a28a721bd1982ce23d3fdbe6960714be54542cd10c5e9c1665", "ref_doc_id": "98cc6f61-4959-47d8-9b52-9d9113037a59"}, "582e079c-2360-4dce-902d-e40ae4354fa1": {"doc_hash": "fe9a3ad3387ca1e71f2d40f5980f350a3e537bc5ce12ec670b6351f3296c20cf", "ref_doc_id": "e8b7c9e8-6645-4aec-8f45-f4dd18e35dff"}, "1ea78891-5b04-4ee0-9725-5e2b13632947": {"doc_hash": "6fc904473cd4bd4fe9c4e15619fc6856f4f45556f9b29e3630ff2f53217458d4", "ref_doc_id": "8b42b374-4b68-48dd-81e2-66429f31a7e9"}, "ccadba87-d980-42f4-b921-b8d001e6f36e": {"doc_hash": "9b94fd0d4038bf484c7f268691667eeddc3fb40864c7e19c721a4c5f977488cf", "ref_doc_id": "0260d65c-88d7-40f2-9dea-c7f2c0641e19"}, "58ab9838-950c-4053-914a-3e12e95d0dd4": {"doc_hash": "1e27535f0395f964a1b04d113be5a61fa3b69f5da1ecfc64dd6b2bd953ee4b9a", "ref_doc_id": "52b6b13f-0153-47f6-bf11-94cc62c72001"}, "25aa0be8-6cdb-4f24-9623-91ec8ae25635": {"doc_hash": "4e7518a69a125647003cbf7ef6d71c24d99ae750cce7f09423463b13e05a99c7", "ref_doc_id": "6e4fefb9-005a-4784-ae24-29ad4358f53a"}, "7dacb244-2740-45bf-93d0-5dfafc75decf": {"doc_hash": "d4ef05b919b0ab08628888daf9ac95d16a02b05db8f8887813a1267f4c16d8fe", "ref_doc_id": "26c53517-9bf4-40c1-a7f0-9be5fc0cae1d"}, "c73b6650-3a06-4b2c-83c8-0ba936298b29": {"doc_hash": "f39bdebe5bf66b262ae7c05901c58992a3ffa24c193c3fe97241987679e78dd3", "ref_doc_id": "2e6569f8-ea8b-449b-b85e-d8e3ed7a2548"}, "ee2dd707-7e3f-4ff9-9158-9a34edf52264": {"doc_hash": "4a4bc55df8ed468cbda28796c913f3838ef425f5dab0e57fe7c1c9b5e1b412eb", "ref_doc_id": "00501aa2-e3bc-4bc5-a0f8-2514db95ae56"}, "adbc07a9-1ca8-4e10-8654-065ab0564cbd": {"doc_hash": "ac88d6722dd293fb65789df3fa35f9d179d74f91fd1a062267b3bf7473d5fe6a", "ref_doc_id": "00501aa2-e3bc-4bc5-a0f8-2514db95ae56"}, "0b7d9814-b190-42cc-acbf-f2c6d5be4faa": {"doc_hash": "77ada0dba0f92e009567585ecc710d7799e5de85dfb3a23fcc4555aaa0705edc", "ref_doc_id": "dd82ef3b-362f-429f-94ed-78b4d02e9b73"}, "9e33f263-73be-440b-b69e-dda9e9f51fb1": {"doc_hash": "17744e8b5d448e0efaeaeb2f3e3cfb3942fc4869f376bc3aa20dc33df3453d00", "ref_doc_id": "dd82ef3b-362f-429f-94ed-78b4d02e9b73"}, "ab53c038-da4a-4daf-b8a6-6220997dcf4b": {"doc_hash": "3edf9c377cf3f3ac83969362a2b0ba433e3040e074a6048f5af465bc26d1e50d", "ref_doc_id": "44689381-06a7-41a8-b39b-b7f61185ffaf"}, "6465504f-dbd4-41ab-a25c-993a46b966af": {"doc_hash": "c91cc9c62aa6ddbe258eb1b515c08b6635ae92d2b41c13866713f97f0414f476", "ref_doc_id": "44689381-06a7-41a8-b39b-b7f61185ffaf"}, "933f05dd-5c86-444a-a415-b90187bfc346": {"doc_hash": "221f7494d55116da6adb0fc4b47d404b3acf24277d811fa248748439dc1b863d", "ref_doc_id": "80d027b1-4e89-4290-92b5-5cd5bc479f0f"}, "bfc1bccd-b193-4da5-83a6-0bc7adf74b42": {"doc_hash": "9ec4180eb9884336ac1c999f1901164238a6c3d95dc23ba0e81440eaf523adce", "ref_doc_id": "790ac20b-1cac-4e60-aed0-10b7a37f3ab2"}, "63f67500-3c72-4de5-9535-f3db1698b72f": {"doc_hash": "070a0363f3d1441c57442ac3961166df69fff57c0fc2f4dbef7912061c553969", "ref_doc_id": "4844296c-c520-442e-83e1-03e996168065"}, "b93ebcfa-d2c7-488e-a480-9e7a8b628627": {"doc_hash": "178b671ccbd7d5c888f15e063eea8c7a0e5e13e4c751e9db5d5651fb9ecb9239", "ref_doc_id": "40d7ae4f-be1e-4932-a65a-a16b93fd20d9"}}, "docstore/data": {"ca105563-483d-40fe-80f1-6f6f756a34bf": {"__data__": {"id_": "ca105563-483d-40fe-80f1-6f6f756a34bf", "embedding": null, "metadata": {"file_name": "About us page.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\About us page.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 24292, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "59fbecda-6156-4f58-a7c7-22664ae007d6", "node_type": "4", "metadata": {"file_name": "About us page.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\About us page.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 24292, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "bcc78ca0352a10338a62ac80924dbd5a61c66ebc2f5397b22525ae97c6e93b46", "class_name": "RelatedNodeInfo"}}, "text": "About Us\u00a0\n\nOur story\u00a0\n\n\n\ni2e leads digital transformation for the life sciences industry through best-in-class innovative technology solutions. Our market leading execution capabilities and domain expertise help pharmaceutical companies, biotech, and healthcare organizations deliver innovations that create a healthier world.\u00a0\n\nWe help R&D, clinical development, commercialization, pharmaceutical sciences, drug safety, regulatory functions accelerate time-to-value, prioritize industry-leading innovation, and establish portfolio leadership.\u00a0\n\n\n\nNamed one of the fastest growing private companies in the US in the 2023 Inc. 5000 list, i2e Consulting is life sciences preferred partner for digital transformation. We are ISO9001 and ISM27001 certified which is a recognition of our commitment towards continuous improvement of process and data security.\u00a0\n\n\n\nOur values\u00a0\n\nCustomer focused\u00a0\n\nWe want to be your preferred partner for digital transformation. That means being upfront about our capabilities, when we can meet them and when we think we can\u2019t. That\u2019s why you will find our team is sought after as solution advisors by senior decision makers in life sciences.\u00a0\n\n\n\nPeople first\u00a0\n\ni2e at its core is a People First organization. This value demonstrates our commitment to the well-being, growth, and fulfillment of individuals within our community. By fostering a people-first culture, we believe in harnessing the collective strength of our people to drive lasting success and shared prosperity.\u00a0\n\n\n\nExcellence\u00a0\n\nWe drive excellence in the solutions that we deliver, the expertise that we provide and the impact that we create. We believe that through this commitment to excellence, we are contributing to the advancement of medical discovery and progress.\u00a0\n\n\n\nInnovation-led\u00a0\n\nIn the realm of healthcare data and analytics, we relentlessly pursue and champion innovation. Our innovation lab creates tech breakthroughs that are customer focused. Our commitment to continuous innovation enables us to be trusted advisors to our customers, empowering pharmaceutical research to thrive in an era of unprecedented challenges in discovery and progress.\u00a0\n\n\n\nDiversity\u00a0\n\nWe recognize the strength in varied perspectives and backgrounds. By fostering an inclusive environment, we harness diverse talents, ideas, and experiences, driving innovation and excellence in our pursuit of healthcare excellence.", "start_char_idx": 0, "end_char_idx": 2403, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b4f9d316-86ec-4b5d-a537-19ea4959f52f": {"__data__": {"id_": "b4f9d316-86ec-4b5d-a537-19ea4959f52f", "embedding": null, "metadata": {"file_name": "Change Management-Planisware.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Change Management-Planisware.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 27611, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "25cec983-7e0c-4f6e-80d7-91bc7d77de2d", "node_type": "4", "metadata": {"file_name": "Change Management-Planisware.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Change Management-Planisware.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 27611, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "8b9c68adb1e717294fdde1a55f87c4bf06a8801e35d5b8b5b674ee1bf04d1fb4", "class_name": "RelatedNodeInfo"}}, "text": "Change Management with i2e Consulting: Adopting Planisware\n\n<explore our services>\n\n\n\n\n\n\n\nWhy do you need Change Management?\n\nDigital PPM solutions like Planisware, comes with a promise of streamlining your processes, eliminating data siloes and much more. However, reaping these benefits depends on how well the change management is handled. \n\nWithout Change Management\n\nWith Change Management\n\nStake holders feel surprised and show resistance to change\n\nStake holders feel supported, educated and well-informed\n\nLow adoption rate resulting in extended project timelines\n\nQuick and seamless adoption with little impact on project timelines\n\nLimited stakeholder involvement; lack of buy-in\n\nActively engage stakeholders at all levels throughout the process\n\n\n\nLimited or no formal training programs; ad-hoc knowledge transfer\n\nComprehensive training programs tailored to different user roles\n\nLimited support available; users may feel abandoned or frustrated\n\nOngoing support through various channels (documentation, FAQs, etc.)\n\nLimited monitoring and evaluation; inability to measure success or identify issues\n\nEstablish governance mechanisms to monitor progress and track performance metrics\n\n\n\nA well-organized change management \n\nSmoothens transition by addressing resistance \n\nProvides necessary training, \n\nAligns processes\n\n Ensures effective communication\n\nMitigates risks\n\nOptimizes ROI\n\nOur PPM experts are not only well-versed with Planisware but are also experienced in anticipating and tackling potential change management challenges. This will ensure a 100% success rate in adopting Planisware, both technically and culturally.\n\n\n\nOur Approach\n\nChange Readiness Assessment: We begin by conducting a comprehensive evaluation of various change readiness factors within your organization. This assessment covers areas such as:\n\nEvaluating the leadership\u2019s readiness in supporting and going ahead with the change initiative.\n\nAssessing the organization's culture to embrace change, including factors such as risk tolerance, openness to innovation, and willingness to collaborate.\n\nAssessing the skills and competencies of employees to gauge their readiness to adapt to and effectively utilize Planisware.\n\nPlanning: Based on the findings of the assessment, team i2e will work closely with your organization to develop tailored mitigation strategies to address identified challenges and resistance points. Finally, our team will provide actionable recommendations and a roadmap for change management.\n\nTraining and skill development: Team i2e will also offer comprehensive training programs to ensure stakeholders have the necessary skills and knowledge to effectively use Planisware. This training may be tailored to different user groups based on their roles and responsibilities within the organization. \n\nFeedback mechanisms: Throughout the change process, i2e Consulting will establish feedback mechanisms to gather input from stakeholders and address any concerns or challenges in a timely manner. This continuous feedback loop ensures that stakeholder perspectives are considered and incorporated into the implementation strategy.\n\nContinuous Improvement: Change management doesn't end with the initial change management. Our team will also support your organization in monitoring adoption, gathering feedback, and continuously improving processes to drive long-term success with Planisware.\n\nWhy choose i2e?\n\nTrusted Planisware Partner\n\nA strong understanding of the platform's capabilities and best practices, i2e Consulting can tailor its change management approach specifically to maximize the benefits of Planisware for your organization.\n\nComprehensive Approach\n\nComprehensive approach to change management, encompassing all the stakeholders, ensuring every aspect of the change process is carefully managed to drive successful adoption and long-term success.\n\nTailored Planning\n\n Tailored change management solutions that are customized to fit your organization's specific needs, goals, and challenges from small medium businesses to large enterprises.\n\nProven Track Record\n\nA proven track record of successful Planisware implementations and change management initiatives to guide through the change process with confidence, minimizing risks and maximizing outcomes.", "start_char_idx": 0, "end_char_idx": 4291, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c71ad92a-e708-4900-8774-85d47de4f308": {"__data__": {"id_": "c71ad92a-e708-4900-8774-85d47de4f308", "embedding": null, "metadata": {"file_name": "Clairvoyance 2.0.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Clairvoyance 2.0.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 34361, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6cf2ecc2-6aaf-474b-ac39-51d09571ba7a", "node_type": "4", "metadata": {"file_name": "Clairvoyance 2.0.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Clairvoyance 2.0.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 34361, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "02e0b0f559488f8b7acac2fabe2e4a70afd7349ab4b5df553279f77920d8179e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6501bc42-c37b-4bec-be37-a8dff4869c9a", "node_type": "1", "metadata": {}, "hash": "a9e4af759d7d5f3b3e8281950086d5becbcba48b338b74f45eee0f02708f05cf", "class_name": "RelatedNodeInfo"}}, "text": "Clairvoyance: End-to-end analytics\n\nOur proprietary project portfolio and forecasting platform, Clairvoyance, harnesses cutting-edge predictive analytics to generate highly accurate and reliable forecasts that inform strategic decisions throughout your product's lifecycle. Whether choosing the best asset development plan, mapping market entry strategies, navigating access and reimbursement landscapes, or optimizing supply chain operations, Clairvoyance equips you with foresight to drive commercial success.\n\nAbout Clairvoyance\n\nClairvoyance offers a consolidated view of the project portfolio, providing senior executives with a powerful tool for data-driven decision-making. Efficiently managed project data can provide crucial financial and operational metrics such as project delivery milestone dates, development cost forecast, and revenue forecasts, with appropriate risk adjustments based on Probability of Technical and Regulatory Success (PTRS) and potential market events. Clairvoyance automates project data integration, data aggregation and summarizes crucial portfolio metrics and portfolio insights, all in one consolidated dashboard.\n\nWhy Clairvoyance?\n\nThe biopharmaceutical R&D industry presents a high-risk, high-value business model which depends on solid strategic portfolio management capabilities to fully exploit the near-term potential of inline brands while optimizing future pipeline growth through disciplined R&D investment and targeted business development. Biopharma pipeline development lifecycles have traditionally been long and as a consequence,  fast and integrated decision tools were not a priority for this sector.  With recent breakthrough in scientific discovery and the emergence of more personalized disease therapy modalities affecting the shape, speed, cost and competition in clinical development, there is an emerging urgency to develop robust pipeline analytics to better understand and manage risk, secure value and sustain corporate growth.\n\nThe biopharma industry is data rich but their traditionally siloed scientific, development and commercial functions have made it difficult to assemble the pipeline knowledge required to prepare real-time portfolio insight, analysis and investment options. Traditional approaches of deploying fragmented point solutions or custom one-off projects simply cannot scale to meet the evolving needs of your organization. Point solutions provide temporary fixes but lack the adaptability for long-term robustness. While custom builds allow for tailored solutions, their static nature cannot persist or flex with your changing priorities and market dynamics. You're forced to compromise - sacrificing control for rapid customizability or vice versa. Biopharma organizations have now realised the importance of investing in enterprise data architectures and technologies to align essential but disparate data from across the organization to enable data driven decisions to the top of the value stream.  This is a huge step forward for the industry and precisely where Clairvoyance fills the need.  Good decision making is as much an art as it is a science.  The fit-for-purpose decision analytics platform was designed by industry leading practitioners who are battle-hardened in strategic portfolio management.  They have architected and developed a portfolio decision platform,  configurable to interface with standard enterprise data systems and custom fit to adapt to \n\nClairvoyance presents a better path forward that doesn't require trading off governance for agility. This enables you to establish a future-proof architecture for comprehensive data integration, advanced analytics, and democratized insights tailored to your unique business processes.\n\nWith a unified data and analytics platform purposely built for life sciences, you can maintain full control while empowering ongoing customization aligned to your strategic roadmap. This powerful pairing of enterprise governance and autonomous configuration finally breaks the constraints of past approaches. As a leader driving transformation, you now have a way to truly future-proof your data and analytics investments without compromise.\n\nCentralized and customizable: Clairvoyance has centralized data aggregation from across your project portfolio, removing the challenges of data living in silos. Its comprehensive dashboard view, KPI reporting and interactive controls, customizable alerts and notifications enable you to access on-demand reports and insights. \n\nAutomated real time data synchronization: Real-time data ensures your forecasts are based on the latest information, reducing the risk of basing decisions on outdated or inaccurate data. This can lead to more precise forecasts and a better understanding of trends, enabling you to identify potential issues or opportunities as they arise. This allows for quicker adjustments to strategies and resource allocation, potentially giving you a competitive edge.\n\nDirect access to project performance: You get access to project performance, any time that you want, improving governance, transparency, and accountability.", "start_char_idx": 0, "end_char_idx": 5131, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6501bc42-c37b-4bec-be37-a8dff4869c9a": {"__data__": {"id_": "6501bc42-c37b-4bec-be37-a8dff4869c9a", "embedding": null, "metadata": {"file_name": "Clairvoyance 2.0.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Clairvoyance 2.0.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 34361, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6cf2ecc2-6aaf-474b-ac39-51d09571ba7a", "node_type": "4", "metadata": {"file_name": "Clairvoyance 2.0.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Clairvoyance 2.0.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 34361, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "02e0b0f559488f8b7acac2fabe2e4a70afd7349ab4b5df553279f77920d8179e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c71ad92a-e708-4900-8774-85d47de4f308", "node_type": "1", "metadata": {"file_name": "Clairvoyance 2.0.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Clairvoyance 2.0.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 34361, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "e0a220f7e88102a60bb189d8e876575df02fb0c03fd60be623bbb2ec4783bfa7", "class_name": "RelatedNodeInfo"}}, "text": "How you can use Clairvoyance to drive better decisions:\n\nPortfolio and Therapeutics area (TA) Strategy: Whether it is dynamic scenario analysis or driving therapeutic innovation, Clairvoyance can accelerate your forecasting accuracy driving growth, value, and revenue. It helps you to predict business risk and optimize R&D portfolio value. Clairvoyance also helps you drive scenario-based portfolio and project planning.\n\nResearch and Development: Improve R&D productivity through our Live innovation Benchmarking Bench to Market. You also get insights about market landscape, market dynamics, and R&D pipeline and portfolio analysis. \n\nForecasting: Clairvoyance helps you in revenue forecast projections, patient / epidemiology forecasts, indication and asset level forecast. You can drive demand forecasting, oversee sales performance dashboards, right from regional to country level at a click. \n\nResourcing: Clairvoyance allows you to drive real time tracking of resource allocation, workload visualization, oversee project progress\n\nLicensing/M&A/Partnering: Assess augmentation opportunities, drive asset prioritization for licensing and other partnering opportunities.\n\nCommercial Strategy: Evaluate market share impact, monitor key competitive threats, assess and augment eNPV and Internal rate of return (IRR).", "start_char_idx": 5137, "end_char_idx": 6457, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1658a190-c1b2-48ba-90aa-cdfce6409f0d": {"__data__": {"id_": "1658a190-c1b2-48ba-90aa-cdfce6409f0d", "embedding": null, "metadata": {"file_name": "Clairvoyance 3.0.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Clairvoyance 3.0.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25664, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "fca7c5d1-758d-4241-89b4-eb2967a7ab39", "node_type": "4", "metadata": {"file_name": "Clairvoyance 3.0.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Clairvoyance 3.0.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25664, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "5675940d0befe54154250f81ca90037a0e151d6bd50c58fba236a8461d76431d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "81702a86-f4d2-408d-baf7-a7c685ce62cb", "node_type": "1", "metadata": {}, "hash": "a7c0c821cefcb67050be7a31d7151ca601c72f32f9f9f8679cf0e02c899eb14c", "class_name": "RelatedNodeInfo"}}, "text": "Clairvoyance: End-to-end analytics\n\n\n\nMake portfolio decisions with confidence with Clairvoyance by your side \n\n\u00a0 \n\nBiopharmaceutical R&D operates through a high-risk, \thigh-value business model, relying heavily on strategic portfolio management to maximize the potential of inline brands and driving future pipeline growth through R&D investments and targeted business development programs. Long pipeline development lifecycles in the past did not mandate fast and integrated decision tools.\u00a0 With increasing late-stage failures, focus on life cycle throughput, emergence of more personalized disease therapy modalities affecting the shape, speed, cost, and competition in clinical development, there is an emerging urgency to develop robust pipeline analytics to better understand and manage risk, secure value, and sustain growth.\n\n\n\nOur proprietary project portfolio and forecasting platform, Clairvoyance, generates highly accurate and reliable forecasts that inform strategic decisions throughout your product's lifecycle. Whether choosing the best asset development plan, mapping market entry strategies, navigating access and reimbursement landscapes, or optimizing supply chain operations, Clairvoyance equips you with foresight to drive commercial success.\n\n\n\n\n\nAbout Clairvoyance\n\n\n\nClairvoyance is a portfolio integration platform that enables a quick analysis of portfolio performance and trade-offs, guided by best practices in portfolio data architecture and harmonised business practices.\u00a0 To enable the collection and alignment of portfolio and project data from across the enterprise, pre-built standardised data interfaces are built into Clairvoyance to enable the rapid integration of enterprise source data such as timing, cost, revenue, and risk. This helps in delivering aggregated results and insights via intuitively designed analytic dashboards and visualisations.\n\n\n\n\n\nHow can Clairvoyance help you?\n\nCentralize decision making platform for your portfolio at a click.\n\n\n\nOne dashboard, many decisions: Clairvoyance offers a consolidated view of the project portfolio, providing senior executives with a powerful tool for data-driven decision-making. Clairvoyance automates project data integration, data aggregation and summarization of crucial portfolio metrics and insights, all in one consolidated dashboard.\u00a0\n\nEfficiently managed project data can provide crucial financial and operational metrics such as project delivery milestone dates, development cost forecast, and revenue forecasts, with appropriate risk adjustments based on Probability of Technical and Regulatory Success (PTRS) and potential market events. \n\n\n\nRisk visibility for informed decisions: Get visibility into aggregate risks (clinical, regulatory, commercial) at each risk gate in your development cycle to understand costs and timing decisions. Clairvoyance aggregates internal and external information (competitive intelligence) at every stage to help you take the right decisions about time-to-market, launch and commercialization that maximize the economic value of your clinical assets.\n\n\n\nEvidence based decisions: Clairvoyance helps portfolio leaders remove bias from decision making, whether it is patient forecast or revenue forecasts. We help therapy area leaders avoid pitfalls such as focus on short term trade-offs that derail long-term organizational growth, concessions arising due to lack of data visibility into the asset pipeline, answering what-if scenarios confidently.\n\n\n\n\nClairvoyance for Big Pharma\n\n\n\nThe traditionally siloed scientific, development and commercial functions in biopharma companies have made it difficult to assemble the pipeline knowledge required to prepare real-time portfolio insight, analysis, and investment options. To enable visibility and transparency, portfolio leaders have looked to either point solutions or custom development.\n\n\n\nTraditional approaches of deploying fragmented point solutions or custom one-off projects simply cannot scale to meet the evolving needs of your organization. Point solutions provide temporary fixes but lack the adaptability for long-term robustness. While custom builds allow for tailored solutions, their static nature cannot persist or flex with your changing priorities and market dynamics. You're forced to compromise - sacrificing control for rapid customizability or vice versa.\n\n\n\nOur fit-for-purpose decision analytics platform has been designed by industry leading practitioners who are highly sought after advisors in strategic portfolio management.\u00a0 They have architected and developed a portfolio decision platform,\u00a0configurable to interface with standard enterprise data systems and custom fit to adapt to existing systems.\n\n\n\nAs an enterprise-scale R&D dashboard platform, Clairvoyance provides an unparalleled level of visibility into your entire R&D pipeline, enabling you to track and monitor projects across multiple therapeutic areas, phases, and geographies. With real-time data integration from various sources, you can make informed decisions based on accurate and up-to-date information, minimizing risks, and maximizing operational efficiencies. Our solution offers advanced analytics and reporting capabilities, allowing you to identify trends, forecast outcomes, and optimize resource allocation. Customizable dashboards and intuitive visualizations empower cross-functional teams to collaborate seamlessly, facilitating data-driven decision-making and streamlining communication across departments.\n\n\n\nClairvoyance for small biotech companies", "start_char_idx": 0, "end_char_idx": 5556, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "81702a86-f4d2-408d-baf7-a7c685ce62cb": {"__data__": {"id_": "81702a86-f4d2-408d-baf7-a7c685ce62cb", "embedding": null, "metadata": {"file_name": "Clairvoyance 3.0.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Clairvoyance 3.0.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25664, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "fca7c5d1-758d-4241-89b4-eb2967a7ab39", "node_type": "4", "metadata": {"file_name": "Clairvoyance 3.0.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Clairvoyance 3.0.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25664, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "5675940d0befe54154250f81ca90037a0e151d6bd50c58fba236a8461d76431d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1658a190-c1b2-48ba-90aa-cdfce6409f0d", "node_type": "1", "metadata": {"file_name": "Clairvoyance 3.0.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Clairvoyance 3.0.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25664, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "cebb124f5f6adbca3ea6a976d6d3d6a65e649cc721aad7e966fa111d79bbfc44", "class_name": "RelatedNodeInfo"}}, "text": "Clairvoyance for small biotech companies\n\n\n\nWith numerous companies vying for limited molecule opportunities, as an emerging biotech company, managing the R&D pipeline, while establishing differentiation and demonstrating value proposition is crucial. With multiple projects in various stages of development, it's crucial to have a comprehensive view of your pipeline to make informed decisions and drive success. Our biotech dashboard solution is designed to provide you with the visibility and insights you need to maximize your R&D efforts.\n\n\n\nOur user-friendly dashboard presents a clear and concise overview of your entire pipeline, allowing you to track projects, monitor progress, and identify potential bottlenecks or risks. With customizable reports and real-time data updates, you can stay ahead of the curve and make data-driven decisions that align with your strategic goals.\n\nOur solution seamlessly integrates with your existing systems, ensuring a smooth transition and minimal disruption to your workflow. Our team of experts will work closely with you to understand your unique requirements and tailor the dashboard to meet your specific needs.", "start_char_idx": 5516, "end_char_idx": 6677, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "cda50a1e-e7f1-440b-9c51-ed6a5acc1303": {"__data__": {"id_": "cda50a1e-e7f1-440b-9c51-ed6a5acc1303", "embedding": null, "metadata": {"file_name": "ESG website.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\ESG website.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25588, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "f7e729ac-6e8b-4149-b301-941074f48622", "node_type": "4", "metadata": {"file_name": "ESG website.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\ESG website.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25588, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "d2f516d71484fdd89e31b38214b87fa313972311ccdc084bbd910b34b269abe7", "class_name": "RelatedNodeInfo"}}, "text": "Our ESG commitment is based on the following pillars: \n\nStrategic adaptation: We have clear signposts on our ESG goals. i2e is a remote first organization, encourages the use of green energy at major worksites and offsites, championing the cause of responsible business travel and adopting a charter for net zero target attainment.\n\nOperational resonance: We have worked up and downstream across both our offerings and operations to drive alignment with our ESG goals.\n\nHere is a summary of i2e\u2019s ESG goals:\n\nEnvironmental: Destination Net Zero\n\ni2e works with some of the biggest organizations in the Oil & Gas (O&G), Pharma, and Technology industries. We recognize that net zero standards are the critical enablers for innovation and top line and bottom-line growth and through our technological interventions we are helping our clients in carbon intensive industries in creating better and faster paths to net zero emissions.\n\nOur practice areas, whether it is PPM or Data Analytics, are helping O&G majors improve productivity, efficiency, and re-channel investments back into the business for green growth practices. Our work with the R&D departments of Big Pharma helps improve inventory management, reduce costs along the entire supply chain (cost savings due to prediction accuracy, reduction in mismatch due to product expiration and transit timelines), deliver demand matched / just-in-time SKUs, while reducing the carbon load of the entire supply chain.\n\nWe have been supporting petrochemical majors in tracking HSE (Health\t, Safety, Environment) incidents through our implementations, leading to transparency in HSE incidents and help them drive better institutionalized safety practices across current/leading/lagging indicators.\n\nWe\u2019ve helped an information services organization modernize the entire IT infrastructure, digitalization their entire catalogue, driving the adoption of digital literature.\n\nSocial: Focus on triple bottom line growth\n\nAs a socially responsible organization, i2e helps our clients achieve triple bottom line growth: financial, social and environmental, across their supply chain, project management, data and R&D functions. \n\nOur data analytics and AI/ML implementations leverage small data settings but help drive adaptive or reinforcement learning that helps clients drive more inclusive hiring, across neurodiverse groups. \n\n\n\ni2e champions the cause of inclusive business practices and has driven numerous social impact programs with government and civil society stakeholders. A significant part of our workforce is comprised of people from underprevileged backgrounds. i2e has provided them intensive workforce training, adaptive infrastructure, and work opportunities, helping create grassroots level change.\n\nGovernance: Helping organizations manage Risk and Opportunity Oversight.\n\nThe area that i2e impacts and influences most significantly in corporate governance is Risk and Opportunity Oversight.\n\nThrough our data service offerings, we help enforce good data governance practices. As per research, organizations have to bear upto $12.9 million annually as costs for bad data1. The cost of bad data and data debt extends into years, creating a vicious cycle of poor strategies and sub optimal performance.\n\ni2e\u2019s service offerings help create good data governance practices, making insights extraction and strategic decision making timely and accurate.\n\nWe have helped a Big Pharma organization in driving governance review and voting protocols for milestone reviews. i2e helped build a centralized governance portal, to manage all the review meetings, and to capture and showcase outcomes from a single point view. This helped improve the auditing process at the organization by incorporating automation in auditing workflow, reducing audit cycle times, and management requests and improving observations closed.\n\nWe remain committed to becoming a responsible vendor partner to our client organizations. Our commitment to our ESG goals is reinforced throughout our operations be it delivery or talent acquisition.", "start_char_idx": 0, "end_char_idx": 4070, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "260be4ec-081c-407f-9b7d-64b81fe3d8d7": {"__data__": {"id_": "260be4ec-081c-407f-9b7d-64b81fe3d8d7", "embedding": null, "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9", "node_type": "4", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "e9a3218a7da7e59cbfd11de35754ed239a56da1f5ea1c5953c9c8883d5b74c28", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "09082eeb-ed0b-4072-9e4c-8342673fee84", "node_type": "1", "metadata": {}, "hash": "7686ce911a8ed911190db7268ef6baf866e57666b5307aa7ab213fe649308073", "class_name": "RelatedNodeInfo"}}, "text": "R&D\n\nDrug discovery\n\nClinical\n\nRegulatory Affairs\n\nPharmacovigilance\n\nMedical Affairs\n\nResearch QA chatbot\n\nAutomated data flow in clinical trials\n\nRegulatory document generation\n\nSignal detection\n\nDocument translation\n\nInternal Portfolio news flow\n\nDigital workforce\n\nLabelling and packaging updates\n\nAdverse event narratives\n\nMedical literature review\n\nProcess improvement insights\n\n\n\n\n\n\n\nMedical imaging data capture\n\nPredictive Analysis\n\n\n\n\n\n\n\n\n\nCognitive molecule research\n\n\n\n\n\n\n\n\n\ni2e\u2019s gen AI offerings in R&D\n\n\n\nI. Drug Discovery\n\n\n\n1. Research Q&A Chatbot\n\n\n\nStrapline: Your trusted research companion.\n\nDesigned to accelerate and optimize the way researchers interact with data and insights, our gen AI research chatbot leverages AI and NLP to provide on-demand access to scientific knowledge and research findings. By simulating conversations with a virtual research assistant, our chatbot empowers researchers to rapidly explore complex datasets, generate hypotheses, and uncover novel insights with unparalleled efficiency.\n\nThe gen AI research chatbot serves as a trusted companion throughout the drug discovery journey, offering personalized recommendations, suggesting relevant research articles, and even assisting in experimental design and interpretation. The chatbot accelerates the pace of scientific discovery, enabling researchers to make informed decisions and drive innovation in pharmaceutical R&D.\n\n\n\n\n\nDeployment ready use cases \n\nAccelerated literature review: The chatbot acts as a tireless research assistant, analyzing vast amounts of scientific literature and clinical trial data to identify relevant studies and potential new avenues of research. It can summarize key findings, highlight emerging trends, and surface obscure connections that might be overlooked by traditional methods.\n\nPersonalized support and on-demand insights:\u00a0Researchers can interact with the chatbot in a natural, conversational way. They can ask specific questions about target proteins, disease pathways, or drug interactions, receiving immediate and tailored responses based on the latest scientific knowledge.\n\nRead our case study about implementation of a gen AI research chatbot in a Big Pharma company <here>.\n\nBenefits\n\nImproved research efficiency: The chatbot automates time-consuming tasks like literature review, freeing up researchers to focus on high-value activities like designing experiments and analyzing data.\n\nDemonstrable innovation:\u00a0By facilitating creative problem-solving and identifying new research avenues, the chatbot acts as a catalyst for scientific breakthroughs. If you are looking for a demonstrable application of gen AI in discovery, get started with our gen AI research chatbot.\n\nData-driven decision making:\u00a0 <here>.\n\n2. Internal portfolio news flow\n\n\n\nStrapline: From news, to breakthroughs\n\nManagement of internal portfolio news flow is crucial for driving informed decision-making, optimizing resource allocation, and maximizing the success of drug discovery initiatives. i2e\u2019s internal portfolio news flow offering leverages ML algorithms and NLP techniques to automate the analysis and synthesis of internal portfolio news flow data. By aggregating and analyzing diverse sources of information, including project updates, research findings, and milestone achievements, our solution provides researchers, project managers, and senior leadership with actionable insights in real-time.\n\n\n\n\n\nDeployment ready use cases\n\nPersonalized feed: No more sifting through irrelevant updates. Our portfolio news curation analyzes your research focus and curates a personalized feed highlighting news and developments within your specific portfolio area. This allows you to stay up-to-date on crucial details without wasting time on unrelated information.\n\nProactive signal detection: Early detection of critical signals from within the portfolio is essential. Our portfolio news tracker can scan vast datasets, including internal reports, preclinical data, and competitor updates. It proactively identifies emerging trends and potential roadblocks, allowing you to anticipate challenges and adjust development strategies as needed.\n\nPredictive insights & trend analysis:\u00a0i2e\u2019s portfolio news tracker assesses historical data and projects trends to predict potential milestones, delays, or resource gaps within your portfolio. This allows for proactive resource allocation and risk mitigation, ensuring your projects stay on track.\n\nBenefits\n\nImproved decision making: By providing a clear, personalized view of your portfolio's progress, our portfolio news tracker empowers researchers and leadership to make more informed decisions about resource allocation, project prioritization, and overall development strategy.\n\nImproved collaboration: The i2e portfolio news tracker fosters communication and collaboration within your research teams. The AI-curated feed ensures everyone is on the same page regarding portfolio progress, promoting teamwork and streamlining communication channels.\n\nIncreased efficiency:\u00a0By eliminating information overload and providing focused updates, our solution frees up valuable time for researchers. This allows them to focus on core research activities, leading to increased efficiency and overall team productivity.\n\n\n\n3. Cognitive Molecule Research", "start_char_idx": 0, "end_char_idx": 5319, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "09082eeb-ed0b-4072-9e4c-8342673fee84": {"__data__": {"id_": "09082eeb-ed0b-4072-9e4c-8342673fee84", "embedding": null, "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9", "node_type": "4", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "e9a3218a7da7e59cbfd11de35754ed239a56da1f5ea1c5953c9c8883d5b74c28", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "260be4ec-081c-407f-9b7d-64b81fe3d8d7", "node_type": "1", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "6182870e86de978f86ab4c4ad1b259df80353598f9122f0a6f55628c865afbc4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c4855293-ab9e-4763-bdc9-d092b9c68e9c", "node_type": "1", "metadata": {}, "hash": "87ebb745a6ba7910fb4a65bf9ca43bdb27db598053befbdfddb08f30527485cf", "class_name": "RelatedNodeInfo"}}, "text": "3. Cognitive Molecule Research\n\n\n\nStrapline: Accelerate molecular design intelligence\n\ni2e\u2019s gen AI capabilities in cognitive molecule research help you navigate the increasingly complex challenges of drug discovery innovation. Our customized turnkey drug discovery solution from target to preclinical development help in making drug discovery efficient. We help biopharma companies in advancing their preclinical programs through best-in-class AI driven molecular design.\n\nDeployment ready use cases\n\nImproved candidate selection: By predicting molecular properties, activity against specific targets, and potential adverse effects, teams can select candidate molecules with higher likelihoods of success. This reduces the risk of late-stage failures and improves the quality of the drug pipeline.\n\nOptimized resource allocation: Insights into structure-activity relationships, synthetic feasibility, and therapeutic potential, enable your teams to allocate resources more effectively. This ensures that resources are directed towards the most promising molecules and research directions.\n\nAccelerated drug discovery: Enable your teams to drive faster identification of lead compounds, virtual screening of compound libraries, and de novo design of molecules. i2e\u2019s capabilities in AI led cognitive molecule research accelerates the drug discovery process, reducing the time and cost required to bring new therapies to market.\n\nBenefits\n\nReduced development risks:\u00a0Identify predictors for success, reducing the risk of late-stage clinical trial failures, saving valuable time and resources.\n\nStronger patent portfolios: Refine and scale the ability to identify novel and patentable drug candidates to develop the next generation of cognitive therapies.\n\nIncreased success rates: Identify and optimize more efficacious, safer, and patentable drug candidates. This increases the likelihood of successful clinical trials and regulatory approval, ultimately leading to commercial success and therapy area leadership.\n\n4. Process improvement insights\n\n\n\nStrapline: Augmenting process intelligence\n\nThe path from initial target identification to candidate nomination is long and arduous, plagued by inefficiencies across disparate processes and teams. For early-stage drug design, our solution serves as a collaborative co-pilot by rapidly synthesizing insights, streamlines knowledge mining, protocol writing, report generation, and experiment planning, automatically generating first drafts that scientists can adapt.\n\nDeployment ready use cases\n\nProcess optimization: Our process improvement insights offering helps to you project/create timelines, resource allocation, and project documentation based on historical data, identifying processes which have historically faced stalls or disruptions. This will help you identify bottlenecks such as slower screening, inefficient data analysis, or lack of timely communication between teams.\n\nPredictive modeling and risk assessment: Learning from historical data, our solution can predict potential safety concerns and efficacy outcomes for candidate drugs early in the discovery process. This allows for informed decision-making and mitigation strategies for potential risks. The outcomes can then be directed for predictive modelling and risk assessment.\n\nData integration and collaborative research: Our analytics solutions integrate various data sources like biological databases, clinical trial data, and real-world evidence. This facilitates data-driven research, promotes collaboration within research teams, and allows for real-time optimization of the drug discovery process, improving time-to-insights for the discovery process.\n\nVirtual screening and lead generation: Enlist our AI-powered virtual screening of massive chemical libraries to identify molecules with high affinity for the target protein. This accelerates the process of finding promising drug leads compared to traditional high-throughput screening methods.", "start_char_idx": 5289, "end_char_idx": 9266, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c4855293-ab9e-4763-bdc9-d092b9c68e9c": {"__data__": {"id_": "c4855293-ab9e-4763-bdc9-d092b9c68e9c", "embedding": null, "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9", "node_type": "4", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "e9a3218a7da7e59cbfd11de35754ed239a56da1f5ea1c5953c9c8883d5b74c28", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "09082eeb-ed0b-4072-9e4c-8342673fee84", "node_type": "1", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "1e982ab56952d2facd25d3d7cc0ffd97b902e28419ac4c2fd8e7238528587aab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5dff48db-0ec0-46c9-837a-a535a58749a3", "node_type": "1", "metadata": {}, "hash": "488a10b426057a91ef5756ee0f3a0fbb158b51152c5753f7630fd499ca356cb3", "class_name": "RelatedNodeInfo"}}, "text": "Benefits\n\nProactive optimizations: You can identify potential bottlenecks or challenges in ongoing projects, making proactive adjustments before actual delays. For example, you may detect a resource shortage for a crucial stage ahead of time, allowing you to explore alternative approaches or resource allocation strategies.\n\nAccelerated decision making: Leverage pattern identification and trend prediction to drive informed decision making quickly.\n\n5. Predictive Analysis\n\nStrapline: Predict tomorrow, discover today\n\nOur solutions in predictive analytics have helped discovery teams in lead prioritization and safety assessment. Whether it is analyzing vast chemical libraries, or drug databases our predictive analytics solutions have helped discovery teams in predicting patient response to treatment options, optimizing trial design, improving patient selection criteria, endpoint selection, predicting likelihood of success for drug candidates early in the discovery process.\n\nDeployment ready use cases\n\nMarket forecasting: Analyze market trends, competitor data, and patient demographics to forecast the commercial potential of drug candidates. We enable you to make informed decisions about investment priorities, licensing opportunities, and market entry strategies.\n\nClinical trial optimization: We enable your teams to analyze historical clinical trial data to identify factors associated with trial success, such as patient demographics, treatment protocols, and endpoint selection. This helps optimize trial design, patient recruitment strategies, and resource allocation to maximize the likelihood of trial success.\n\nDisease modeling: We can integrate multi-omics data and clinical information to develop predictive models of disease progression, patient response to treatment, and disease outcomes. This enables researchers to simulate different scenarios, identify biomarkers, and personalize treatment approaches for improved patient outcomes.\n\nBenefits\n\nEarly efficacy and safety insights: We enable your teams to identify potential issues before they derail clinical trials. Our predictive analytics solution parses vast datasets, including historical clinical data, protein structures. This allows for early prediction of a drug candidate's potential efficacy and safety profile, enabling researchers to focus on those with the highest chance of success and minimize the risk of late-stage failures.\n\nOptimized lead selection:\u00a0Our predictive analytics solutions help you select promising drug leads removing guesswork. By predicting a candidate's potential for success in clinical trials, it guides researchers towards the most promising leads, optimizing resource allocation and accelerating the development process.\n\nBetter clinical trial outcomes: We empower your team to design more efficient trials by predicting patient response rates and optimizing trial parameters such as dosage and duration. This leads to smaller, more targeted trials that provide conclusive results faster, and help you improve time-to-market.\n\n\n\nII. Clinical", "start_char_idx": 9270, "end_char_idx": 12331, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "5dff48db-0ec0-46c9-837a-a535a58749a3": {"__data__": {"id_": "5dff48db-0ec0-46c9-837a-a535a58749a3", "embedding": null, "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9", "node_type": "4", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "e9a3218a7da7e59cbfd11de35754ed239a56da1f5ea1c5953c9c8883d5b74c28", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c4855293-ab9e-4763-bdc9-d092b9c68e9c", "node_type": "1", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "53540a06482d670141571bf241813fcad3cd2252b0482c1ea3fcb1319395a11c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9869ce23-1379-43e3-bb66-ce51ccf7d09d", "node_type": "1", "metadata": {}, "hash": "13a138b091cf4f69f137be3a73a62e8886c6350b837b3105e39282207213d311", "class_name": "RelatedNodeInfo"}}, "text": "II. Clinical\n\n\n\n1. Automated data flow in clinical trials\n\nStrapline: Driving trial data flow excellence\n\ni2e\u2019s solutions for data flow in clinical trials ensure data acts a unifier allowing for seamless integration and analysis across all sites. We enable clinical trials teams to have access to high quality data, comprehensive dashboards, and interactive data visualizations throughout the trial lifecycle, accelerating clinical decision making. However disparate the data sources may be, be it Patient Reported Outcomes (PRO) or data from wearables, our data flow offering can extract relevant data points, standardize formats, and integrate disparate data sources seamlessly, reducing manual data entry errors and ensuring data consistency and completeness.\n\ni2e\u2019s data flow solutions act as the guardian of data quality, identifying anomalies and inconsistencies, prompting for corrections, or suggesting potential missing values based on historical data. This real-time cleaning process ensures data integrity and avoids delays in downstream analysis.\n\nDeployment ready use cases\n\nData standardization: Clinical trials often involve multiple clinical sites with varying data formats. Our data flow solutions for clinical trials can convert data into a standardized format, allowing for seamless integration and analysis across all sites. This eliminates the need for time-consuming manual data harmonization efforts.\n\nIntelligent data enrichment: i2e\u2019s data flow solutions can analyze unstructured data like patient notes, imaging reports, and wearable device readings. It continuously evaluates data streams, extracts relevant information, standardizes formats, and flags potential anomalies for review. This enriches existing data sets, reduces errors that could jeopardize trial validity, providing a more comprehensive picture of patient health and trial progress.\n\nEarly risk identification: \u00a0Early detection of potential risks is crucial in clinical trials. i2e\u2019s data flow solutions analyze historical data and identifies patterns that might indicate patient safety concerns or potential trial delays. This allows for proactive intervention and mitigation strategies, ultimately improving patient safety and trial outcomes.\n\nAutomated data visualization and real-time insights:\u00a0Generate insightful visualizations from complex datasets that provide you with real-time insights into key performance indicators, recruitment trends, and potential areas of concern.\n\nBenefits\n\nImproved decision making: Improved data quality and visualizations enable clinical trial sponsors and investigators to take proactive measures to address issues to improve trial outcomes.\n\nImproved efficiency:\u00a0Enable your researchers to focus on critical analysis and decision-making, not data wrangling. Automating data flow eliminates manual tasks, leading to significant cost savings and improved operational efficiency.\n\nRegulatory compliance:\u00a0Real-time data validation ensures data integrity, minimizing the risk of errors and delays during regulatory submissions. Our solutions helps you meet stringent regulatory requirements and avoid setbacks.\n\nFaster time to market:\u00a0By streamlining data management and facilitating faster analysis, our AI solution accelerates clinical trial timelines. This allows you to get life-saving treatments to patients sooner.", "start_char_idx": 12319, "end_char_idx": 15667, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9869ce23-1379-43e3-bb66-ce51ccf7d09d": {"__data__": {"id_": "9869ce23-1379-43e3-bb66-ce51ccf7d09d", "embedding": null, "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9", "node_type": "4", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "e9a3218a7da7e59cbfd11de35754ed239a56da1f5ea1c5953c9c8883d5b74c28", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5dff48db-0ec0-46c9-837a-a535a58749a3", "node_type": "1", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "d9db2610a03aa3e0453630433e2aeb739b9325b59653777bad3d28c91679be8d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "82ff1241-dd62-41b2-9748-082f33895ac3", "node_type": "1", "metadata": {}, "hash": "8502e992d4f6db83cd9446812f5e8cfae528a0bf31a7a75e95ffde6ae563ef7f", "class_name": "RelatedNodeInfo"}}, "text": "2. Digital Workforce\n\nStrapline: Smart teams, smarter results\n\nDrive better trials outcomes by deploying virtual assistants that can manage repetitive tasks like data entry, scheduling patient visits, and managing regulatory documents. i2e\u2019s digital workforce solutions not only automate and execute repetitive tasks but also analyze vast datasets to predict potential enrolment roadblocks and suggest recruitment strategies. By freeing up researchers\u2019 time and streamlining workflows, our digital workforce solutions empower you to focus on what matters most \u2013 scientific innovation and patient care.\n\nRight from streamlining patient recruitment, data collection, scheduling patient visits, data entry, and adverse event reporting, our digital workforce solutions are designed to accelerates trial timelines. Advanced analytics capabilities provide real-time insights into trial progress, patient outcomes, and protocol adherence, enabling proactive decision-making and risk mitigation. We help your clinical trial teams can maximize productivity, improve data quality, and ultimately expedite the delivery of life saving therapies to patients.\n\nDeployment ready use cases\n\nEnrolment experience:\u00a0Imagine a tireless assistant handling administrative tasks like scheduling patient appointments, collecting routine data, and generating standard reports. Our digital workforce offering automates these repetitive tasks, freeing up valuable time for human researchers to focus on high-level analysis and patient care.\n\nEnhanced patient engagement:\u00a0Our AI chatbots can connect with patients remotely, answering basic questions, providing medication reminders, and collecting patient-reported outcomes. This not only improves patient experience but also increases data collection efficiency.\n\nRecruitment diversity:\u00a0Traditional recruitment methods often have geographical limitations. Our solutions can leverage diverse language capabilities and cultural awareness to expand patient recruitment efforts globally, leading to more representative trial populations.\n\nBenefits\n\nEnhanced patient safety and monitoring:\u00a0i2e\u2019s digital workforce chatbots can monitor patient progress remotely, detecting potential adverse events early on. This enables proactive intervention and improved patient safety throughout the trial.\n\nImproved clinical trial outcomes:\u00a0Our AI digital workforce reduces operational costs and streamlines clinical trial processes, leading to faster completion times.\n\nEnhanced data quality and compliance:\u00a0Our digital workforce offering ensures data consistency and reduces human error in data collection. This enhances data quality and facilitates compliance with regulatory requirements.\n\nRead more about our digital workforce offering in this whitepaper <here>\n\nIII. Regulatory Affairs\n\n\n\nStrapline: Approach regulatory submissions with greater confidence.\n\nStreamline compliance processes and enhance decision-making for your teams by helping them automate document management, submission preparation, and regulatory intelligence gathering. i2e\u2019s regulatory solution analyzes vast amounts of regulatory data, and provides real-time insights into evolving requirements and precedents, enabling proactive compliance strategies. Advanced analytics capabilities identify potential risks and opportunities, guiding regulatory strategy and decision-making. With i2e\u2019s by their side, regulatory affairs teams can improve efficiency, accuracy, and agility in navigating complex regulatory landscapes, ultimately accelerating product approvals and ensuring compliance with global regulations.\n\n\n\n\n\n1. Regulatory Document\u00a0Generation\n\n\n\nStrapline: For more focus on the science.\n\ni2e can help you approach regulatory submissions with confidence. Our regulatory offering helps you in generation and formatting of regulatory documents, such as submissions, dossiers, and reports. We help you streamline content creation and review processes, reducing time-to-market and minimizing errors. Regulatory affairs teams can leverage i2e\u2019s regulatory document generation capabilities to efficiently produce high-quality documents, optimize resource allocation, and maintain compliance with regulatory authorities, ultimately expediting the approval of life-saving therapies for patients.\n\nDeployment ready use cases\n\nEnhanced dossier preparation:\u00a0Assembling comprehensive regulatory dossiers can be a time-consuming task. Our AI automates data extraction from clinical trials and pre-clinical studies, ensures consistent formatting, and generates compliant regulatory documents. This frees up valuable time for your team to focus on strategic analysis and review.\n\nPredictive modeling and risk assessment:\u00a0Anticipate potential regulatory hurdles through insights generated by analyzing historical data and identify potential areas of concern within your regulatory submissions. Drive proactive mitigation strategies and smoother interactions with regulatory agencies.\n\nReal-time regulatory intelligence:\u00a0Stay up-to-date with evolving regulations through regulatory updates and alerts that might impact your submissions. This will ensure your regulatory strategy remains compliant and adapts to the ever-changing landscape.\n\nBenefits\n\nEnhanced consistency & error reduction:\u00a0Manual drafting can lead to inconsistencies and errors, jeopardizing regulatory approval. i2e\u2019s regulatory document generator ensures consistent formatting and terminology across documents, minimizing human error and maximizing compliance.\n\nAdaptive and customizable output:\u00a0Keep up-to-date with evolving regulations with adaptive AI that incorporates the latest regulatory guidelines into document generation. Additionally, it allows for customization based on specific drug types and submission requirements.\n\nImproved regulatory confidence:\u00a0Approach regulatory submissions with greater confidence, knowing your documents meet the highest standards of accuracy and completeness.\n\n\n\n\n\n\n\n2. Labelling and packaging\u00a0updates", "start_char_idx": 15671, "end_char_idx": 21659, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "82ff1241-dd62-41b2-9748-082f33895ac3": {"__data__": {"id_": "82ff1241-dd62-41b2-9748-082f33895ac3", "embedding": null, "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9", "node_type": "4", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "e9a3218a7da7e59cbfd11de35754ed239a56da1f5ea1c5953c9c8883d5b74c28", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9869ce23-1379-43e3-bb66-ce51ccf7d09d", "node_type": "1", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "23b569ddd2e04f225dac7e372982737362091facea349a0336c711bff49569f2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "06bee9fa-1f69-45a2-80d0-e51596471aed", "node_type": "1", "metadata": {}, "hash": "a7d10dd7dcb41853fadd5b53aae2390868f5c332f5762dbda6503381b01df7f0", "class_name": "RelatedNodeInfo"}}, "text": "2. Labelling and packaging\u00a0updates\n\n\n\nStrapline: Intelligent labelling automation\n\nCreation and verification of packaging and labeling materials, ensuring adherence to regulatory requirements and industry standards can be tedious. Leverage our gen AI capabilities to analyze product specifications, regulatory guidelines, and labeling requirements. We help you ensure accuracy, consistency, and compliance throughout the labeling lifecycle. Our advanced image recognition capabilities verify label accuracy and integrity, reducing the risk of errors and regulatory non-compliance. With i2e\u2019s regulatory adherence solutions, regulatory affairs teams can streamline labeling workflows, mitigate risks, and accelerate time-to-market for critical therapies.\n\nDeployment ready use cases\n\nAutomated content generation:\u00a0Regulations change and labelling and packaging workflows need to adapt. We can analyze regulatory updates and automatically generate compliant content for your product labels and packaging inserts.\u00a0This eliminates the need for manual updates, minimizing human error and ensuring accuracy.\n\nBatch record documentation: Our regulatory adherence solutions can assist in the creation and maintenance of batch record documentation by automating data entry, verification, and compliance checks. This improves data integrity, traceability, and audit readiness for regulatory inspections.\n\nLabeling standardization: Our packaging and labelling solutions can help you standardize labeling formats and content across product lines and regions to ensure consistency and compliance with regulatory requirements. This enhances brand identity, reduces labeling errors, and facilitates global market access.\n\nRegulatory reporting: Generate regulatory reports and submissions related to packaging and labeling, such as safety updates, labeling changes, and regulatory notifications. This streamlines regulatory reporting processes and ensures timely compliance with regulatory requirements.\n\nBenefits\n\nImproved efficiency:\u00a0Maintaining consistency across different languages and regional regulations can be complex. Automating content generation and updates significantly reduces the time and resources required to maintain compliance. Our solution tailors labelling and packaging content to specific regulatory requirements, ensuring global compliance and minimizing the risk of market access delays.\n\nFaster time-to-market:\u00a0Proactive identification of potential issues and streamlined updates minimize delays in getting compliant products to market. This allows you to capitalize on market opportunities and enable treatment access to patients sooner.\n\nProactive risk assessment and mitigation:\u00a0Our solution can identify potential regulatory concerns with existing labelling and packaging based on historical data and regulatory trends. This allows you to proactively address potential issues before they escalate into expensive product recalls.\n\nEnhanced regulatory confidence:\u00a0By ensuring accurate and compliant labelling and packaging, we empower you to navigate regulatory interactions with greater confidence, minimizing the risk of non-compliance issues.\n\nIII. Pharmacovigilance\n\nUse i2e\u2019s signature offerings in PV to become an active co-pilot in all of your PV processes. Whether it is reducing data overload or manual processing, or signal identification and prioritization, leverage our advanced gen AI capabilities to drive PV transformation. Our capabilities can perform contextual analysis to evaluate severity, onset, or potential life-threatening situations, enabling you to assign human interventions for high priority cases first. Beyond individual reports, our solutions can analyze broader trends within the data, uncovering hidden patterns and potential safety signals that might go unnoticed with traditional methods. This proactive approach empowers pharmacovigilance teams to stay ahead of potential issues and ultimately improve patient safety.\n\n\n\n1. Signal Detection\n\n\n\nProposed name: SignalFinder\n\nStrapline: Drive proactive signal vigilance\n\nConventional methods of signal detection from adverse event reports are time-consuming, resource-intensive, and can miss important signals, compromising patient safety. i2e\u2019s PV offerings help optimize PV signal detection processes, by leveraging advanced ML algorithms and NLP techniques to analyze vast amounts of real-world data, including adverse event reports, electronic health records, case reports, medical literature, FDA communications, clinical trials data, and social media mentions. By identifying patterns, trends, and anomalies within these data sets, we enable you to identify signals of potential safety concerns quickly and accurately.", "start_char_idx": 21625, "end_char_idx": 26345, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "06bee9fa-1f69-45a2-80d0-e51596471aed": {"__data__": {"id_": "06bee9fa-1f69-45a2-80d0-e51596471aed", "embedding": null, "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9", "node_type": "4", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "e9a3218a7da7e59cbfd11de35754ed239a56da1f5ea1c5953c9c8883d5b74c28", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "82ff1241-dd62-41b2-9748-082f33895ac3", "node_type": "1", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "2fcb2ef03f9da38609dea4f7756e18ab43cab74faa84a08c6de1c84435de70e4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ae6f91f4-9c2f-4427-9a28-1e6f429df9aa", "node_type": "1", "metadata": {}, "hash": "99052e960c95ce1279899bffad1b6674ebfaa14a0bed60ca1bf670e5b813c33b", "class_name": "RelatedNodeInfo"}}, "text": "Deployment ready use cases:\n\nAutomated case screening & prioritization: Leverage our AI solutions to analyze vast amounts of data on adverse drug reactions (ADRs) reported from various sources, automate the initial screening of these reports, filter them based on pre-defined criteria like specific patient demographics, drug combinations, or reported symptoms.\n\nReal-time signal identification and pattern recognition: Process incoming ADR reports to identify potential emerging signals \u2013 clusters of similar adverse events that might indicate a safety concern. By identifying potential signals early on, design interventions for human review and investigation before the issue escalates. This allows for faster intervention and minimizes potential patient harm.\n\nText mining and automated extraction of key information: Drive extraction of key information from ADRs, such as specific symptoms, timelines, and suspected medications through our advanced text mining capabilities. Drive faster analysis and categorization of ADRs, facilitating the identification of potential signals and trends within the data. Reduce workload for human reviewers and allow them to focus on interpretation and insights.\n\nAutomated data visualization and interactive reporting: Leverage our data visualization and reporting capabilities to summarize ADR trends, signal patterns, and potential safety concerns. These reports can be interactive, allowing human reviewers to drill down into specific details.\n\nBenefits\n\nImproved decision making: SignalFinder parses unstructured text data within Adverse Event Reports (AERs), social media mentions, can identify hidden patterns and false positives, and uncover insights undiscovered by human review, improving chances of early detection. Early detection of safety signals allows for quicker intervention, flagging easily missed symptoms, potentially preventing serious adverse events and improving patient safety. This enables PV teams to focus on higher-level analysis and critical decision-making.\n\nAutomates case triage: SignalFinder can automate the initial sorting of reports, categorizing them based on pre-defined indicators of severity, rapid onset, or potential life-threatening situations. This frees up human expertise for more complex analysis and decision-making.\n\n\n\nEnhanced compliance: Proactive identification of safety signals demonstrates a commitment to patient safety and facilitates smoother regulatory interactions.\n\nDownload our whitepaper on the role of AI in signal detection here.\n\n2. Adverse Event Narratives\n\nProposed Name: ADRWatch\n\nStrapline: Faster insights, better decisions.\n\nImprove safety monitoring and patient experience by automating the detection, analysis, and reporting of adverse drug reactions. i2e\u2019s ADRWatch analyze adverse events from diverse data sources, such as patient reports, social media, and electronic health records. Real-time monitoring and predictive analytics enable early detection of potential safety concerns, empowering proactive risk management strategies. By streamlining adverse event identification and assessment, we help you prioritize patient drug product quality, regulatory compliance, and patient safety.\n\nDeployment ready use cases\n\nEntity recognition and case prioritization: Our NLP led solution analyzes the narrative text within ADR reports. It can identify and extract key entities such as medications, symptoms, and patient demographics. unstructured text data, saving time and minimizing human error during data entry. Extracted information can then be used for signal detection, trend analysis, and case prioritization.\n\nSentiment analysis and early warning system: Leverage ADRWatch\u2019s gen AI capabilities to analyze the language used in ADR narratives to gauge the severity and urgency of reported events. Prioritize rapid response to narratives with high emotional distress, rapid symptom onset, or potential life-threatening situations. By analyzing sentiment, you can prioritize response time for serious events for immediate review and investigation. This allows for earlier intervention and minimizes potential patient harm.\n\nAutomated text summarization and risk factor identification: Drive summarization of key points and relevant details from the narrative text of ADR reports, identify potential risk factors for adverse events from text, such as specific patient characteristics or drug interactions. Automated summarization allows reviewers to quickly grasp the essence of each report and prioritize those requiring more in-depth analysis. Identifying potential risk factors in the text can further guide investigation and signal detection efforts.\n\nBenefits\n\nImproved data quality:\u00a0Data volume can mask genuine safety signals compromising patient safety. Limited resources and time constraints can overload PV teams, potentially leading to missed or delayed detection of critical safety issues. ADRWatch enables you to isolate signal from noise, improve data quality, identifying triggers that can lead to escalations.\n\nBalancing risk and benefit:\u00a0Our gen AI solution enables you to weigh the potential benefits of a drug against the identified safety concerns. Improved and accurate data along with considerations of patient needs, the severity of the condition being treated, and the availability of alternative therapies enables balanced decision making.\n\nEnhanced regulatory compliance:\u00a0Proactive identification of safety signals demonstrates a commitment to patient safety and facilitates smoother regulatory interactions.", "start_char_idx": 26349, "end_char_idx": 31901, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ae6f91f4-9c2f-4427-9a28-1e6f429df9aa": {"__data__": {"id_": "ae6f91f4-9c2f-4427-9a28-1e6f429df9aa", "embedding": null, "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9", "node_type": "4", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "e9a3218a7da7e59cbfd11de35754ed239a56da1f5ea1c5953c9c8883d5b74c28", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "06bee9fa-1f69-45a2-80d0-e51596471aed", "node_type": "1", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "35ffa4adf8f2c869685cfcb4a105fe39eb874cac9837a1373c865c4670ffb43a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "99fc276a-9d80-4b50-9d4c-f5eff661bd8f", "node_type": "1", "metadata": {}, "hash": "864ac38b1111d724fe9c376a1bd176f8ca2b7c0227b21993372ce049168b28e3", "class_name": "RelatedNodeInfo"}}, "text": "V. Medical Affairs\n\nOur gen AI led offerings in medical affairs help in improving scientific exchange, mitigating compliance risks, and enhancing patient/HCP communication. Right from a virtual assistant that can scan comprehensive research papers, clinical evidence reports, and various scientific journals, translate findings into actionable insights, to more unstructured problems such as sourcing KOLs, analyzing physician sentiments, our offerings help MSL teams to improve medical affairs productivity.\n\n1. Document Translation\n\n\n\nProposed name: IntelliScript\n\nStrapline: Global insights, local precision\n\nTranslating scientific literature accurately is crucial and IntelliScript helps in translation of all kinds of scientific assets, be it regulatory documents, product labels, patient information leaflets, regulatory submissions, into multiple languages. Our high-fidelity translation ensures compliance with international regulatory requirements and facilitates market access for pharmaceutical products across diverse regions.\n\nIntelliScript can translate data from clinical trial protocols, consent forms, study documents, research articles, medical information leaflets, enabling global collaboration and participation in clinical research studies. Leverage IntelliScript to drive better global scientific exchange, foster collaboration among researchers across sites, and facilitate evidence-based medical practice worldwide.\n\n\n\nDeployment ready use cases:\n\nMultilingual content creation: Whether it is creating clinical trial materials or patient safety and adherence documents, effortlessly reproduce high quality medical information across multiple languages to support global medical teams. Ensure consistent and accurate medical terminology across translated documents by integrating your portfolio/organization\u2019s specific glossaries.\n\nSocial listening: Get global market insights for your medical affairs team. Get access to information translated and analyzed from different sources such as social media discussions, news articles, and healthcare forums in various languages, providing you with a comprehensive understanding of local prescription trends, HCP surveys.\n\nMultilingual chatbots: AI-powered chatbots or virtual assistants can answer HCP questions and provide medical information in multiple languages. These tools can offer 24/7 support and personalized guidance, regardless of location or language.\n\nBenefits\n\nIncreased efficiency: Drive communication standardization and collaboration between distributed medical teams and reduce time-to-market for launching in new markets.\n\nEnhanced regulatory compliance: Submit translated documents for regulatory approvals faster. Leverage AI-driven accurate translations that comply with specific regional regulations, minimizing the risk of delays or rejections.\n\nImproved patient care:\u00a0Accurate and timely translations facilitate communication with international healthcare professionals, regulatory bodies, and potentially, patients themselves. This global reach allows you to share critical medical information more effectively, ultimately contributing to improved patient care worldwide.\n\n\n\n2. Medical Literature Review\n\n\n\nProposed name: Literature review accelerator\n\nStrapline: From insights to intelligence\n\nKeeping up with the ever-expanding body of biomedical research and evidence is no longer a challenge with i2e\u2019s medical literature review accelerator. It offers advanced capabilities to accelerate and enhance medical literature review processes across medical journals, case reports, conference proceedings, clinical trials data, and more. With the review accelerator, medical and frontline teams can receive rapid updates and insights about new developments in therapy areas.\n\nAutomated literature search and prioritization: Amplify your literature review process with i2e\u2019s literature review accelerator which can parse vast clinical databases, identifying relevant publications based on pre-defined criteria and automatically filtering out less pertinent studies. This saves time and ensures you focus on the most impactful research.\n\nAutomated data extraction and summarization: Leverage i2e\u2019s literature review accelerator to enable your teams to extract key findings from complex scientific papers. Our solution automatically summarizes key findings, highlights emerging trends, and identifies potential areas of interest for your specific therapeutic area or drug candidate. It can also parse competitor publications, clinical trial data, and social media mentions to identify opportunities and threats in a particular therapy area.\n\nSignal detection and trend analysis: Our advanced AI capabilities analyze the content of publications to identify emerging scientific trends and potential breakthroughs relevant to your therapeutic area. This allows you to anticipate future directions in medical research.\n\nBenefits\n\nImproved decision making: With i2e, your medical affairs team delivers higher quality evidence-based insights, regarding product development, clinical trial design, and can drive scientific exchange with healthcare providers for better clinical outcomes.\n\nFaster time-to-market and increased ROI: By accelerating the literature review process and facilitating informed decision-making, we help you bring innovative treatments to market faster.\n\n3. Medical imaging data capture", "start_char_idx": 31905, "end_char_idx": 37297, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "99fc276a-9d80-4b50-9d4c-f5eff661bd8f": {"__data__": {"id_": "99fc276a-9d80-4b50-9d4c-f5eff661bd8f", "embedding": null, "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b82e9f3c-09d4-4226-878f-f98c664a83c9", "node_type": "4", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "e9a3218a7da7e59cbfd11de35754ed239a56da1f5ea1c5953c9c8883d5b74c28", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ae6f91f4-9c2f-4427-9a28-1e6f429df9aa", "node_type": "1", "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "00c3798c7a6d7898d74aadc15e0b2b39aa6858e75510a6f28adeca8d15fc6bf4", "class_name": "RelatedNodeInfo"}}, "text": "Proposed name: MediPix\n\nStrapline: Imaging intelligence, redefined\n\nAnalyzing imaging data accurately improves trial design, leading to more reliable and reproducible results. Accurate analysis helps drive efficacy and safety, enables early risk detection, and improves patient safety. \n\nConventional medical imaging analysis can be complex and time-consuming, often leading to delays in diagnosis and patient care.  Our team of data scientists has been working on AI-led diagnostics, enriching insights generation with interpretive intelligence. Through our work in AI-led diagnostics we aim to help further develop the practice of digital /computational pathology, helping teams reduce time and bias in diagnosis, improve quality and time-to-insights, drive higher diagnostic accuracy, and ultimately help design better clinical trials and improve patient experiences.\n\nDeployment ready use cases:\n\nImage preprocessing and enhancement: Detect and remove noise artifacts from digital pathology images,\u00a0such as scanner noise or staining inconsistencies.\u00a0This improves image clarity and allows for more accurate analysis by pathologists. Normalize staining across images,\u00a0ensuring consistency and facilitating comparison between slides. Benefit from image sharpening and resolution enhancement allowing for better visualization of finer cellular details crucial for diagnosis.\n\nImproved patient selection: Identify patients who meet specific inclusion criteria more accurately and efficiently. Empower your teams to streamline the patient recruitment process, ensuring that clinical trial cohorts are well-defined and representative of the target population. \n\nEnhanced end point detection: Leverage AI led analysis to detect and quantify disease-related endpoints, such as tumor size, lesion volume, or tissue inflammation. This objective assessment of endpoints improves the reliability and reproducibility of trial outcomes, reducing variability and enhancing statistical reporting.\n\nAnomaly detection and early risk identification: Use early detection of potential treatment side effects to identify subtle anomalies that might be missed by human eyes. Design early interventions to minimize patient risk.\n\nImproved trial outcomes: Monitor treatment response effectively, make proactive adjustments to treatment regimes, reduce bias and subjectivity, and improve the patient outcomes, trial success rates, reliability, and regulatory acceptance of trial results.\n\nBenefits:\n\nImproved clinical trial outcomes: Use better imaging data to empower researchers to design more targeted clinical trials and select patients most likely to benefit from a specific treatment.\n\nAccelerated drug approval and patient access:\u00a0Faster data analysis and improved clinical trial design leads to quicker regulatory approvals, allowing patients to access life-saving treatments sooner.\n\nRead our whitepaper on gen AI applications in medical imaging here.\n\n\n\n\n\n\n\nWhy i2e for gen AI offerings?\n\nValue proposition\n\nExtensive domain expertise: Leverage i2e\u2019s extensive domain expertise combining AI/ML capabilities with deep R&D knowledge to develop bespoke solutions that augment your existing workflows and processes. Our AI is purpose-built to identify and eliminate bottlenecks and accelerate innovation across drug discovery, clinical development, regulatory, and safety initiatives.\n\nResponsible AI: i2e is commitment to ethical, explainable, and responsible AI that prioritizes human-machine collaboration. Our solutions empower scientists by expanding innovative capabilities while ensuring humans remain in control with AI serving as a co-pilot. Transparency and trust are core principles built into our AI solutions.\n\nDemonstrable value: Our AI solutions span data infrastructure to operationalization and change management. We support full lifecycle AI deployments, from LLM training on proprietary datasets to embedding AI into production, PV, clinical ops, and chemistry platforms via APIs and systems integration. Our services ensure sustainable AI adoption and value realization.\n\n\n\n2", "start_char_idx": 37301, "end_char_idx": 41380, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "2ae79675-0c62-43a3-b248-c8bfed8c7b74": {"__data__": {"id_": "2ae79675-0c62-43a3-b248-c8bfed8c7b74", "embedding": null, "metadata": {"file_name": "i2e\u2019s 4 phase road mapping.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\i2e\u2019s 4 phase road mapping.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 22928, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "98cc6f61-4959-47d8-9b52-9d9113037a59", "node_type": "4", "metadata": {"file_name": "i2e\u2019s 4 phase road mapping.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\i2e\u2019s 4 phase road mapping.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 22928, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "3f3c160c314120a28a721bd1982ce23d3fdbe6960714be54542cd10c5e9c1665", "class_name": "RelatedNodeInfo"}}, "text": "Planisware Partnership Services\n\ni2e's 4-Phase Road Mapping \n\n<Explore our services>\n\n\n\nOur consulting experts will help you create a long-term plan for phasing Planisware implementations, optimizing its use and expanding functionality over a 2\u20133year time horizon. As part of the road mapping, we also establish governance mechanisms and checkpoints to monitor progress, track performance metrics, and ensure alignment with strategic objectives throughout the implementation journey.\n\nWe designed our road mapping framework in 4 phases. By taking a phased approach to Planisware implementations our consulting experts ensure that your organization can realize the full potential of the platform while minimizing disruption and maximizing business value. Through careful planning, execution, and ongoing optimization, we help you achieve your project and portfolio management goals and drive sustainable growth and success.\n\nInitial implementation phase\n\nWe start by focusing on the implementation of Planisware, ensuring that the core functionalities are successfully deployed to address immediate needs. During this phase, our consultants work closely with your team to configure Planisware according to your specific requirements, including customizing workflows, defining user roles, and setting up data structures.\n\nStabilization and optimization phase\n\nOnce the initial implementation is complete, we enter a stabilization and optimization phase aimed at fine-tuning the system for optimal performance. Our consultants conduct thorough testing and quality assurance to identify any issues or areas for improvement, addressing them promptly to ensure system stability.\n\nExpansion and integration phase\n\nWe, then shift our focus on expanding the use of Planisware and integrating it with other systems and processes within your organization. This may involve extending Planisware's capabilities to support additional project and portfolio management processes, such as resource management, financial tracking, risk management, or strategic planning.\n\nContinuous improvement phase\n\nThroughout the 2\u20133year time horizon, our consulting experts will provide continuous support to prioritize keeping your Planisware implementation aligned with evolving business needs and industry best practices. Our consultants will stay abreast of the latest updates and advancements in Planisware technology, proactively recommending new features or functionalities that can further optimize your PPM processes.\n\nOur Planisware Experts\n\nBrian Beattie                  Pratik Shinde         Nilesh Nimbhorkar     \n\nInsights", "start_char_idx": 0, "end_char_idx": 2607, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "582e079c-2360-4dce-902d-e40ae4354fa1": {"__data__": {"id_": "582e079c-2360-4dce-902d-e40ae4354fa1", "embedding": null, "metadata": {"file_name": "IT-PPM Setup.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\IT-PPM Setup.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 40482, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "e8b7c9e8-6645-4aec-8f45-f4dd18e35dff", "node_type": "4", "metadata": {"file_name": "IT-PPM Setup.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\IT-PPM Setup.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 40482, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "fe9a3ad3387ca1e71f2d40f5980f350a3e537bc5ce12ec670b6351f3296c20cf", "class_name": "RelatedNodeInfo"}}, "text": "Project and Portfolio Management for IT\n\nEmpowering IT Projects towards excellence\n\n<Explore more>\n\n\n\nTransform your IT-PPM processes for seamless efficiency and unparalleled business impact\n\n\n\nBenefits of Digitally Transforming your IT-PPM Setup\n\nWhat can Digital Project Portfolio Management do for IT Departments\n\nImproved alignment with business strategies: Ensure your IT initiatives are closely aligned with your overall business strategies. \n\nPrioritize projects that deliver the most impact\n\nMaximize the value of your IT investments\n\nOptimized resource management: Gain visibility into resource capabilities, availability, and forecasting.\n\nOptimize resource allocation across projects and portfolios\n\nImprove resource utilization, and better project delivery\n\nDemand Management: Take data backed decisions on prioritizing ideas and subsequent project executions.\n\nDirect resources towards initiatives that promise the highest strategic value\n\nStakeholders focus on initiatives that are likely to deliver desired outcomes\n\nEnhanced project and portfolio governance: Implement robust data governance frameworks, standardized processes, and best practices.  \n\nEnsure compliance with industry standards\n\nMitigate risks and promote consistent project execution\n\nImproved risk management: Enable proactive risk identification, assessment, and mitigation.  \n\nMinimize project disruptions, delays, and cost overruns\n\nEnsure successful project and portfolio delivery\n\nEnhanced scalability and adaptability: Increase scalability and adaptability as your organization's needs evolve.\n\nEasy accommodation of changes in project scope, resource requirements, or business priorities\n\nMake your IT investments agile and responsive.\n\nQuick adoption to latest technologies: Facilitate the easier adoption of emerging technologies\n\nHassle-free and easy adaptation of latest technologies like AI \n\nLeverage advanced analytics for strategic decision-making\n\n\n\nOur Capabilities\n\nCritical Capabilities\n\nStakeholder Collaboration\n\n Change Management\n\n Business Analyst\n\n Risk Management\n\n Performance reports and Dashboards\n\n Data Analytics\n\n Bespoke development\n\nBusiness Expertise\n\nHybrid Project Management, from Agile through traditional waterfall\n\n Demand Management\n\n Strategic Planning and Portfolio Prioritization\n\n Resource Management\n\n Enterprise Architecture\n\n Financial Management\n\nData Analysis \n\n\n\nWe offer comprehensive IT-PPM setup services utilizing Planisware, a leading solution for IT departments, new product development teams, and/ or enterprise PMOs. We can optimize project delivery, streamline processes, and maximize the benefits your IT team provides to the rest of your organization.\n\n\n\nOur Approach\n\nStrategic Road mapping: Develop a comprehensive IT-PPM roadmap aligned with your business strategies and goals.\n\nSolution Design and Implementation: Design and implement Planisware solution that meets your specific IT-PPM requirements. Including setting up resource management, skill management, vendor management and any other custom requirements.\n\nProcess Optimization: Streamline and optimize your IT-PPM processes, such as setting up clear team structures, identifying internal skillsets, defining scope for internal teams and vendors, preparing project templates, and much more.\n\nData Migration and Integration: Seamlessly migrate and integrate your existing data into Planisware, ensuring continuity and data integrity.\n\nCustomization and Extension Development: Develop custom extensions and integrations to unlock Planisware's functionality and meet unique business needs.\n\nIntegrations with existing workflows: Integrating Planisware into your ecosystem either by utilizing Planisware\u2019s OOB integrations or developing bespoke custom integrations.\n\nTraining and Change Management: Provide comprehensive training and change management support to ensure smooth user adoption and maximize ROI.\n\n\n\nWhy choose i2e?\n\n\n\nExpertise: Our team comprises seasoned professionals with extensive experience in PPM consulting and implementation.\n\nCustom Solutions: We understand that each business is unique. That's why we offer customized solutions tailored to your specific needs and objectives.\n\nCertified Planisware Partners: i2e Consulting is a certified Planisware partner and is well-versed with the functionalities of the tool.\n\nContinuous Support: Our commitment doesn't end with implementation. We provide ongoing support and guidance to ensure the long-term success of your PPM initiatives.\n\nCase study\n\n<Lupin>\n\n\n\nTake the first step towards streamlining your IT portfolio management by contacting us today.", "start_char_idx": 0, "end_char_idx": 4625, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "1ea78891-5b04-4ee0-9725-5e2b13632947": {"__data__": {"id_": "1ea78891-5b04-4ee0-9725-5e2b13632947", "embedding": null, "metadata": {"file_name": "Offerings - Strategy & Consulting.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Offerings - Strategy & Consulting.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 26104, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "8b42b374-4b68-48dd-81e2-66429f31a7e9", "node_type": "4", "metadata": {"file_name": "Offerings - Strategy & Consulting.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Offerings - Strategy & Consulting.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 26104, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "6fc904473cd4bd4fe9c4e15619fc6856f4f45556f9b29e3630ff2f53217458d4", "class_name": "RelatedNodeInfo"}}, "text": "Strategy and Consulting\n\nStrapline 1: Helping you maximize value from investments, innovation, and insights\n\nStrapline 2: Driving alignment between science and business\n\nWe help accelerate innovation by helping R&D decision makers optimize their portfolio, support the commercial viability of the pipeline, and drive alignment with corporate strategy.\n\nOur strategy and consulting offerings help you overcome barriers to R&D success, such as focus on short term trade-offs that derail long-term organizational growth, concessions arising due to lack of data visibility into the asset pipeline, answering what-if scenarios confidently. Our domain and technology expertise can help you shorten innovation cycles, project R&D accountability, and avoid \u201csafe\u201d projects that deter the organization from pursuing high-value therapeutics that enable portfolio leadership.\n\nOur expertise spans strategic portfolio management, R&D portfolio management, portfolio decision analytics. We have helped R&D leaders make more confident clinical and business decisions by helping them identify and develop differentiated offerings, prioritize pipelines as per strategic roadmaps, compare portfolio scenarios, while delivering transformative value.\n\n\n\nStrategic Portfolio Management\n\n\n\nStrapline: From pipeline growth to topline growth \n\ni2e\u2019s strategic portfolio management services help portfolio decision makers avoid debilitating short term trade offs to prioritize projects that maximize pipeline and organizational value. \n\nOur strategy and consulting services helps R&D decision makers align R&D efforts with market needs and regulatory demands and help create opportunities for portfolio leadership. We evaluate opportunities to help you maximize the value of your clinical assets through the entire drug lifecycle. We help deliver revenue mapped strategies for portfolio assessment, diversification, therapy area evaluation, and forecasting.\n\nStrategy: We help you evaluate existing unmet needs, market accessibility, early Target Value Propositions (TVPs) to guide right R&D investments decisions. \n\nDevelop: Forecast TVP revenue, drive planned investments across the full projected lifecycle. \n\nMonitor: Evaluate new-to-market innovation proposals, develop trade-off management strategies to monitor portfolio health.\n\n\n\nR&D Portfolio Management\n\nStrapline: From ambiguity to clinical certainty\n\nOur domain experts integrate strategic R&D goals and horizon planning to develop empirical simulation models that can demonstrate probabilities of success for various assets in the R&D portfolio. \n\nWe prioritize top- and bottom-line metrics such as Likelihood of Approval (LOA) and Phase Transition Success Rate (PTSR) of a drug using proprietary ML models, while recommending strategies for value maximization. Our team of experts evaluate strategic deliverables right from opportunity identification, unmet needs, economic value of drug right down to the eNPV and commercialization costs.\n\nValue management: Whether you want to build market or therapy focus, our portfolio management services help you align innovation to strategy, pre-empt and manage portfolio risks.\n\nPredictive analytics: Reduce time-to-market, all through predictive analytics that inform better decisions.\n\nRisk management: Manage project uncertainty to determine project funding/closure. Manage adverse events better by leveraging available institutional and industry knowledge.\n\nData visualization: Guide portfolio review conversations through better data visualizations.\n\n\n\nPortfolio Decision Analytics\n\nStrapline: Aligning portfolio value with organizational value\n\nOur capabilities in predictive analytics help R&D executives drive portfolio value management to identify right optimizations for portfolio growth. Our domain experts help uncover performance insights by leveraging scenario and sensitive analyses, data visualization, while creating a more transparent R&D portfolio and enabling cross-functional collaboration.\n\nCapital budgeting: Drive productive intra-organizational investments by having full visibility over the R&D pipeline.\n\nProject selection: Maximize portfolio value through the right selection of assets and investments.\n\nDecision analysis: Identify uncertainties, create efficient frontiers based on variables like eNPV, and Expected Commercial Value (ECV).\n\nMedical Affairs\n\nStrapline: Get evidence, analytics and insights to drive medical organization excellence.\n\nMedical Affairs teams are increasingly looked at to provide not just scientific insights but strategic leadership as well. The role of Medical Affairs is beyond interacting with provider, payers, and patients segments. It is also about novel interventions such as applying AI to clinical trials, digital HCP interactions, leveraging machine learning in field medical interventions.\n\n\n\nI2e\u2019s offerings in Medical Affairs help you to not just drive medical strategy and medical communications but drive medical organization excellence. \n\n\n\nStrategy: Refine your medical strategy mission, tap into science, evidence and analytics to influence early development, drive awareness during pre-launch phase, and support Continuing Medical Education (CME) throughout post-launch phase.\n\nEvidence: Deliver practice changing data by embedding analytics into your clinical development planning with insights validating disease area to support the ongoing management of evidence-generation plans.\n\nEngagement: Drive better HCP engagement by getting access to deeper insights: Not just KOL influence matrix, but sentiment analysis, identifying upcoming KOLs, and interaction scheduling.", "start_char_idx": 0, "end_char_idx": 5633, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ccadba87-d980-42f4-b921-b8d001e6f36e": {"__data__": {"id_": "ccadba87-d980-42f4-b921-b8d001e6f36e", "embedding": null, "metadata": {"file_name": "Our leadership.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Our leadership.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 236867, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "0260d65c-88d7-40f2-9dea-c7f2c0641e19", "node_type": "4", "metadata": {"file_name": "Our leadership.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Our leadership.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 236867, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "9b94fd0d4038bf484c7f268691667eeddc3fb40864c7e19c721a4c5f977488cf", "class_name": "RelatedNodeInfo"}}, "text": "Founders\n\nSudhir Karanth I Founder and CEO\n\n\n\nSudhir\u00a0Karanth\u00a0is an accomplished leader in the life sciences IT community.  With over 25\u00a0years of experience in the IT\u00a0industry, he has spent the last two\u00a0decades transforming life\u00a0sciences through data, analytics, and AI leadership. Sudhir is responsible for i2e\u2019s strategy, growth, and innovation, identifying opportunities for extending i2e\u2019s market leadership.\n\n\n\nVishal Rane I Co-Founder and COO\n\n\n\nAs COO, Vishal leads market development, organizational transformation, and provides revenue and management leadership. Throughout his career, he has focused on business growth, expanding i2e\u2019s global and regional footprint, and ensuring i2e\u2019s brand recognition amongst life sciences organizations. \n\n\n\nSri Kanagala I Co-Founder\n\n\n\nSri leads i2e\u2019s differentiated delivery architectures by integrating innovative technological solutions. He provides technology vision and leadership to i2e\u2019s experts across AI/ML, Big Data and Cloud. He has led expansion of the service delivery portfolio by adding new service lines, capabilities, and partnerships.\n\n\n\nPrashant Apte I Co-Founder\n\n\n\n\n\n\n\n\n\n\n\n\n\nPrashant has been instrumental in building the business from the grounds up. In the early days managed business development, sales, technology strategy. Now focused in an advisory capacity for achievement of goals and outcomes in the different departments of the business.\n\n\n\nLeadership\n\nCarlos Nunes I Vice President of Portfolio Analytics\n\n\n\n\u00a0\n\nCarlos joined i2e from a 25-year career experience as an industry consultant and a pharma insider in strategic portfolio management and\u00a0digital innovation. He is an industry pioneer\u00a0in designing\u00a0and deploying\u00a0enterprise\u00a0integrated, real-time\u00a0executive\u00a0decision support\u00a0tools to\u00a0enable\u00a0data-driven R&D asset investment analysis, scenario\u00a0planning and portfolio sustainability.\u200b\n\n\n\n\n\nBrian Beattie\u00a0|\u00a0Vice President \u2013 Strategic PPM Roadmap\u200b\n\n\u00a0\n\nBrian is focused on the Portfolio & Project Management solutions. His understanding of business processes combined with technical\u00a0expertise gives him the ability to advise companies seeking to achieve successful outcomes with a strategic PPM roadmap.\u00a0Brian has had\u00a0previous roles in Procurement, Vendor Management, and Solution Delivery.\n\n\n\nPeter Green I Vice President, Analytics\n\n\u00a0\n\nPeter is an Enterprise Analytics\u00a0professional with 18 years of experience. He has had\u00a0previous roles in R&D Data & Analytics, portfolio\u00a0decision analytics and business integration.\u200b\n\n\n\n\n\n\n\nParmod Kumar\u00a0|\u00a0Director Life Sciences \u2013 R&D Transformation and Analytics\u200b\n\n\u00a0\n\nParmod\u00a0has been engaging C-suite, leadership, and client to drive business, growth agenda, decision making, marketing plans and strategy\u200b\n\nB. Pharm; MBA with 17+ years\u2019 experience in Life Science Business Strategy, Consulting, BD & Licensing, Sales, and Marketing Analytics.\u00a0Worked across the product life cycle starting from early drug discovery to patent expiry.\u00a0\u200b\n\n\n\n\n\nBoard of Advisors\n\nJohn Gregory I Strategic Advisor\n\n\u00a0\n\nJohn has over 30 years of experience in delivering global large-scale transformational programs across Life Science domains including leading the digitalization of Pfizer\u2019s Pre-Clinical R&D, Emerging Science & Innovation, and Worldwide R&D Operations. After spending 21-years with Pfizer, John retired from the position of Senior Director within Pfizer\u2019s Digital organization in 2021.\n\n\n\nDave Penndorf I Strategic Advisor\n\n\n\n\n\n\n\n\n\n\n\nDave brings almost two decades of PPM expertise focused on the Life Science industries to the i2e team, advising i2e on Go To Market strategy, PPM best practices and trends in the industry. Dave spent 17 years at Planisware, with such roles as VP of Life Sciences, VP of Business Operations, Director of Consulting, and Solution Architect.\n\n\n\nDave authored the chapters on Project Management Information Systems in the 2023 released book, \"Project Management for Drug Developers\", detailing how to set up your software solutions and data models to meet the needs of project management offices today.", "start_char_idx": 0, "end_char_idx": 4044, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "58ab9838-950c-4053-914a-3e12e95d0dd4": {"__data__": {"id_": "58ab9838-950c-4053-914a-3e12e95d0dd4", "embedding": null, "metadata": {"file_name": "Partner page.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Partner page.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 29164, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "52b6b13f-0153-47f6-bf11-94cc62c72001", "node_type": "4", "metadata": {"file_name": "Partner page.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Partner page.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 29164, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "1e27535f0395f964a1b04d113be5a61fa3b69f5da1ecfc64dd6b2bd953ee4b9a", "class_name": "RelatedNodeInfo"}}, "text": "Our partners\n\nThere should be space for partner logos in the design.\n\ni2e\u2019s strategic partner network helps us provide best-in-class PPM, AI/ML, cloud & hosting solutions for our clients. Our domain expertise and pre-built solutions accelerate time-to-business value and improve RoI for life sciences organizations.\n\nPlanisware\n\ni2e consulting is a part of the Planisware strategic alliance. As implementation and consulting partners, we help organizations implement Planisware Enterprise or Orchestra. In addition, our expertise includes Planisware system integration, portfolio dashboards with Planisware datasets for better decision making. \n\nDataiku\n\nDataiku is one of the world\u2019s leading AI and machine learning platforms, supporting agility in organizations\u2019 data efforts via collaborative, elastic, and responsible AI, all at enterprise scale. Hundreds of companies use Dataiku to underpin their essential business operations and ensure they stay relevant in a changing world, including models driving fraud detection, customer churn prevention, predictive maintenance, supply chain optimization, and much more.\n\nDataiku is built for companies looking to democratize AI across their organization, bringing agility and preparedness to the business through the use of data by everyone from analysts to data scientists. \n\n\n\nSnowflake\n\nWe partnered with Snowflake to help our customers leverage the flexible data management and analytical services of Snowflake. The cloud platform\u2019s Data Cloud connects to dozens of other solutions, to easily extract valuable insights. As a technology partner our team has the expertise to consult and implement Snowflake in line with your business needs.\n\nMicrosoft\n\nWe are gold Microsoft certified solution provider. We specialize in providing up-to-date Microsoft technology-based customer solutions like Cloud Solutions, Project Management, Business Productivity. In addition, under Microsoft Services Provider License Agreement (SPLA), we also provide licenses for software services and hosted applications to end customers.\n\nAWS\n\nWe are an AWS technology and consulting businesses Partner. As a part of the AWS Partner Network (APN),\u202fwe leverage Amazon Web Services to build solutions and services for customers.\u202fThis empowers us with AWS expertise, and uniquely positions us to help companies at various stages of their cloud journey.\n\nAutomation Anywhere\n\nOur technology alliance partnership with Automation Anywhere helps us build, enhance and implement automation solutions.\n\n\n\n\n\nWhy partner with us?\n\nPartnerships are catalysts for a better world. We believe in work that transforms the future of medical research, health outcomes, and patient care.\n\nOur strategic partnerships demonstrate our commitment to advancing healthcare. That\u2019s why have invested in building a partner network program optimized for mutual success. Whether you are an upcoming tech platform or an established market leading brand, we are confident that our partnership will help life sciences organizations solve problems of tomorrow, today. \n\nCreate mission level impact\n\nWe believe in delivering innovations that can generate mission level impact in life sciences. Innovations that impact healthcare and improve outcomes for many years to come.\n\nOur expertise and talent in science, development and business helps us deliver value to our partners while creating impact for customers. Business development, R&D, commercial and regulatory teams rely on i2e to deliver innovative solutions for their biggest problems.\n\nOur collaboration can help you expand your reach, broaden your addressable market, and support innovative use cases in life sciences.\n\nLife sciences focused\n\nOur precision analytics and solution offerings are designed specifically for life sciences organizations by specialists with deep industry expertise. We understand the nature and importance of clinical data, commercial complexity, regulatory obligations and stakeholder dynamics that distinguish this sector. If you want to create cutting edge impact in life sciences, i2e is your partner.\n\nContinuous innovation\n\nThrough our AI Innovation Lab, our focus on lab-to-market, and deep industry expertise, we bring to life some of the most innovative solutions to the most pressing problems in life sciences, helping create industry best practices, driving deployments, adoption, and customer success. Our global network of co-innovation labs and delivery capabilities make us the preferred partner of choice for industry leading products and platforms.", "start_char_idx": 0, "end_char_idx": 4547, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "25aa0be8-6cdb-4f24-9623-91ec8ae25635": {"__data__": {"id_": "25aa0be8-6cdb-4f24-9623-91ec8ae25635", "embedding": null, "metadata": {"file_name": "Planisware consulting content.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Planisware consulting content.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25732, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "6e4fefb9-005a-4784-ae24-29ad4358f53a", "node_type": "4", "metadata": {"file_name": "Planisware consulting content.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Planisware consulting content.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25732, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "4e7518a69a125647003cbf7ef6d71c24d99ae750cce7f09423463b13e05a99c7", "class_name": "RelatedNodeInfo"}}, "text": "Planisware Partnership Services\n\nPPM Consulting\n\n\n\nMaximize success with our Planisware PPM consulting\n\n<explore our services>\n\n\n\nOur Services\n\nNeeds assessment\n\nWe begin by assessing your existing Project Portfolio Management (PPM) processes. Our team will evaluate current workflows, from project initiation to completion. They will also examine your current technology stack and tools in use and identify integration points and potential gaps in the existing system.\n\nImplementation planning\n\nOur team can develop a comprehensive implementation plan, considering the organization's structure, workflows, and industry regulations. They will conduct a detailed analysis of existing workflows and processes to identify areas that require customization in Planisware. Team i2e will work closely with end-users to understand their specific needs to incorporate these into the Planisware configuration.\n\nConfiguration through best practices\n\nAs a trusted Planisware partner and with a track record of successfully implementing digital PPM solutions, team i2e will ensure to configure Planisware following industry standards. Our PPM experts will establish a framework for continuous improvement, incorporating feedback from users. We will also undertake customize dashboards, reports, and workflows to precisely match the needs of pharma decision-makers, providing them with actionable insights.\n\nData migration and integration\n\nOur services do not end with configuration, we also ensure a seamless transfer of existing data to Planisware, minimizing the risk of data loss or corruption during the migration process. As per the business need, we can also integrate Planisware with other relevant systems, such as analytics tools or cloud platforms, ensuring data consistency and enhancing overall functionality.\n\nChange management\n\nUser adoption is crucial to ensure the organization reaps the full benefits of Planisware. As seasoned Planisware experts, team i2e can assist in smooth change management. We offer hands-on and interactive training sessions to familiarize users with the Planisware platform. We also provide ongoing support through various channels, including documentation, FAQs, and dedicated support teams. Thus, ensuring users have access to the resources they need, minimizing disruptions and reinforcing their confidence in using Planisware.\n\n\n\nContinuous improvement\n\nTeam i2e can also assist in establishing a framework for continuous improvement, incorporating feedback from users to enhance user experience and address evolving needs. Be it version upgradations or scaling Planisware to other teams, our team will be there to ensure the best possible use of Planisware in tandem to your evolving needs.\n\n\n\nWhy i2e?\n\nTrusted Planisware Partner\n\n14 years of PPM experience\n\nPlanisware certified and trained team\n\nX no. of Planisware projects delivered", "start_char_idx": 0, "end_char_idx": 2871, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "7dacb244-2740-45bf-93d0-5dfafc75decf": {"__data__": {"id_": "7dacb244-2740-45bf-93d0-5dfafc75decf", "embedding": null, "metadata": {"file_name": "Planisware Upgrade Testing.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Planisware Upgrade Testing.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25526, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "26c53517-9bf4-40c1-a7f0-9be5fc0cae1d", "node_type": "4", "metadata": {"file_name": "Planisware Upgrade Testing.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Planisware Upgrade Testing.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25526, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "d4ef05b919b0ab08628888daf9ac95d16a02b05db8f8887813a1267f4c16d8fe", "class_name": "RelatedNodeInfo"}}, "text": "Planisware Version Upgrade Testing\n\nEnsure a smooth Planisware version upgradation\n\n<Explore our services>\n\nKeeping your Planisware platform up to date is essential for maximizing its potential and ensuring your organization stays at the forefront of project management excellence. i2e's expertise as a certified Planisware partner uniquely positions us to guide you through the intricate process of version upgrades, with a focus on comprehensive testing that guarantees a seamless transition.\n\n\n\nWhy should you opt for version upgrade testing?\n\nMinimized disruptions: Rigorous testing ensures that the upgrade process is smooth and minimizes disruptions to your ongoing projects. This translates into uninterrupted workflows and sustained productivity.\n\nOverhead reduction: We meticulously plan the detailed testing process considering various scenarios. This will reduce the overhead cost and fill any skill set gap.\n\nReduction in timelines: Our experts can plan the testing process in parallel to the upgradation process, this can significantly reduce the upgradation timelines. It also minimizes the impact on critical processes.\n\nZero failure upgradation: Upgrade testing helps in identifying any disruptions early on and fixing them before the actual upgrade. This results in a 100% success rate.\n\nInformed decision-making: Testing helps you identify potential impacts of the upgrade on critical processes with data-backed evidence. This empowers you to take accurate decisions and manage the process strategically.\n\nOur Approach\n\nWe employe a systematic approach to Planisware version upgrade testing, our process is agile and can be tailored to your organization's specific needs:\n\nRequirement analysis: We start by understanding your business objectives, current system configurations, and desired outcomes from the version upgrade.\n\nTest planning: Our experienced team develops a comprehensive test plan, outlining the testing scope, methodologies, and success criteria for the version upgrade.\n\nTest case design: i2e designs detailed test cases, covering various aspects such as functionality, performance, and compatibility with existing integrations.\n\nExecution and validation: Our team executes the test cases, meticulously validating each component of the upgraded system to identify and address any issues promptly.\n\nRegression testing: We conduct regression testing to ensure that existing functionalities remain intact and unaffected by the version upgrade.\n\nDocumentation and reporting: Comprehensive documentation and detailed reports are provided, outlining the testing process, identified issues, and recommendations for resolution.\n\nWhy choose i2e Consulting?\n\nEnd-to-end testing services: From requirement analysis to documentation, i2e Consulting offers end-to-end version upgrade testing services, providing a comprehensive solution for your Planisware platform.\n\nCertified Planisware partner: i2e Consulting is a certified Planisware partner, ensuring that our team possesses the expertise and knowledge required for seamless version upgrade testing.\n\nCustomized solutions: We understand that each organization has unique requirements. Our approach is tailored to your specific business needs, ensuring that the version upgrade testing aligns with your objectives.\n\nCase study\n\nRead all about how we helped a client achieve a zero-failure E7 upgrade through our testing services\n\n< https://www.i2econsulting.com/i2es-upgrade-testing-success-for-planisware-e7x-transition/>\n\nInsights", "start_char_idx": 0, "end_char_idx": 3510, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "c73b6650-3a06-4b2c-83c8-0ba936298b29": {"__data__": {"id_": "c73b6650-3a06-4b2c-83c8-0ba936298b29", "embedding": null, "metadata": {"file_name": "PPM Analytics- Planisware.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\PPM Analytics- Planisware.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 28173, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "2e6569f8-ea8b-449b-b85e-d8e3ed7a2548", "node_type": "4", "metadata": {"file_name": "PPM Analytics- Planisware.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\PPM Analytics- Planisware.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 28173, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "f39bdebe5bf66b262ae7c05901c58992a3ffa24c193c3fe97241987679e78dd3", "class_name": "RelatedNodeInfo"}}, "text": "Planisware PPM Analytics\n\nData-backed portfolio decisions for organizational efficiency \n\n\n\n\n\n\n\nPlanisware is an integrated solution providing a comprehensive view of budgets, forecasts, resources, and actuals for all your projects. This data holds valuable insights which can help in accurate project and portfolio planning. From identifying patterns to predicting outcomes, Planisware's analytics capabilities empower organizations to derive meaningful insights from their project data.\n\ni2e Consulting is a trusted Planisware partner and can assist tailor Planisware to your specific needs. Our PPM experts can also guide you in creating out-of-the-box functionalities within Planisware to create reports and dashboards that matter.\n\n\n\nPortfolio data analysis\n\nPlanisware is an excellent tool to capture and store vast project-related data over time. By leveraging this historical data, decision-makers can understand how various factors influence project outcomes and can guide future decision-making. The platform\u2019s advanced algorithms can identify recurring challenges, optimal resource allocations, or project success factors. These algorithms empower organizations to uncover valuable insights that might go unnoticed in traditional project management approaches. Team i2e can understand business requirements and assist in establishing an advanced analytics pipeline within and around Planisware, to generate real-time insights that are accurate, accessible and aligned with your business goals.\n\nCustomized Reporting and Dashboards\n\nDecision-makers can turn insights into decisions using reports and dashboards. Planisware, at its core, offers comprehensive reporting capabilities that allow users to generate detailed reports. These reports are highly customizable within the Planisware platform, enabling users to tailor them to specific project requirements. i2e's expertise ensures that the reporting and dashboards are finely tuned to meet the unique needs of your organization.\n\nPlanisware's capabilities include real-time data tracking, allowing users to access up-to-the-minute information on project metrics. When coupled with i2e's expertise, this feature becomes even more powerful, providing a dynamic and accurate overview of project progress and performance metrics. The platform is also known for its user-friendly interface, and i2e can ensure the customized reports and dashboards are intuitive and readily understandable.\n\nIntegration with External Data Sources\n\nPlanisware stands out with its remarkable capabilities in seamlessly integrating with external data sources, transforming the way organizations access and utilize information. This means your organization can leverage a diverse range of external data, including market trends, industry benchmarks, and relevant insights. Planisware's integration capabilities ensure that the data from external sources seamlessly flows into the system, eliminating silos and promoting efficient data utilization. \n\nTeam i2e carries expertise in building an effective data pipeline around Planisware to ensure Planisware is well integrated within your ecosystem; couple it with our ability to create custom dashboards, and you will have the power of making data-backed decisions.\n\nPredictive Analytics Modelling\n\nPlanisware\u2019s predictive analytics can analyze data from previous projects and predict future outcomes. Predictions in tasks such as estimating task durations during planning phase, forecasting project budgets, and predicting resource utilization and workloads, can help organizations plan efficiently. This includes identifying areas where additional resources may be needed, reallocating resources based on predicted demand, and overall improving the efficiency of project operations.\n\nTeam i2e can help you achieve an optimized approach to predictive analytics modelling, by tailoring predictive models specific to nuances and intricacies of your projects. This ensures the model captures the intricacies that define your organization's specific challenges and opportunities. As projects evolve and new data becomes available, i2e will ensure the predictive models are updated and refined.\n\nBenchmarking and Comparative Analysis\n\nGain a competitive edge by benchmarking your projects against industry standards and competitors with Planisware's benchmarking capabilities. This feature allows your organization to measure performance metrics, timelines, resource utilization, and other key indicators against established benchmarks, providing a comprehensive view of your projects' relative performance.\n\ni2e brings analytical prowess by enhancing the depth and sophistication of benchmarking analysis. This involves not only comparing numerical data but also interpreting the results in the context of your organization's specific goals, industry trends, and competitive landscape. This insight is invaluable for refining strategies, optimizing processes, and addressing weaknesses, ultimately enhancing the overall efficiency and effectiveness of your projects.\n\n\n\n<Carousal showcasing sample dashboards>\n\n\n\nWhy choose i2e?\n\nWhy i2e?\n\nTrusted Planisware Partner\n\n14 years of PPM experience\n\nPlanisware certified and trained team\n\nX no. of Planisware projects delivered\n\n\n\nInsights", "start_char_idx": 0, "end_char_idx": 5269, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ee2dd707-7e3f-4ff9-9158-9a34edf52264": {"__data__": {"id_": "ee2dd707-7e3f-4ff9-9158-9a34edf52264", "embedding": null, "metadata": {"file_name": "Resource management.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Resource management.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25740, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "00501aa2-e3bc-4bc5-a0f8-2514db95ae56", "node_type": "4", "metadata": {"file_name": "Resource management.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Resource management.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25740, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "f91cde520f3e90bc1e38a202c24606f0a400f08940a5cbad0ae440efa16af779", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "adbc07a9-1ca8-4e10-8654-065ab0564cbd", "node_type": "1", "metadata": {}, "hash": "8a54fb1725e8b5a5d5afdd8945f0133cad60b5caf8a410ec515c56289ad6fa93", "class_name": "RelatedNodeInfo"}}, "text": "Resource management\n\nFor biopharmaceutical companies managing complex product pipelines, effective resource management is critical to developmental success. However, siloed systems and fragmented visibility make it difficult to plan and deploy resources across global projects. This impacts speed, drives up costs, and hinders strategic execution.\n\nRemove uncertainty and guesswork from your decision making with i2e\u2019s resource management suite. Our resource management offerings harness the power of data analytics, allowing you to identify resource gaps or overallocation across your portfolio. This data-driven approach ensures you're making informed decisions about talent allocation, budget prioritization, and project timelines, ultimately leading to more efficient resource utilization, and maximized ROI.\n\nA well-designed resource management system empowers your team with the tools they need to excel. Real-time dashboards and interactive reports provide transparency into project progress and resource utilization. This fosters collaboration, keeps everyone aligned with goals, and allows team members to focus on their core competencies, accelerating the advancement of your most promising drug candidates.\n\nHere are our resource management offerings:\n\nPlanisware \n\nOur dedicated resource management solution built on Planisware's portfolio management platform provides comprehensive visibility and advanced optimization capabilities specifically tailored for unique resource challenges in life sciences.\n\nAt the foundation is a centralized hub consolidating all resource data: skills, roles, capacities, calendars, utilization metrics and more. Robust integration fabrics seamlessly connect this data from downstream HR, finance, and operational systems across your organization.\n\nPlanisware\u2019s out-of-box functionalities for resource management overcome the limitations of traditional spreadsheets and disconnected systems. It acts as a central hub, consolidating data on personnel, budgets, and project timelines into a single, unified platform. This holistic view empowers you to make strategic resource allocation decisions based on real-time insights, prioritizing the projects with the highest potential impact.\n\nWhy Planisware resource management?\n\nData driven decision making: Go beyond simply tracking resources. With PEX reporting, resource managers have the provision to forecast allocation by resource/project and also the ability to modify existing allocations, change/swap resources, create new resource allocations. Advanced analytics unlock valuable insights into resource gaps and overallocation across your portfolio. This lets you optimize talent assignments, budget distribution, and project timelines with surgical precision.\n\nMore efficient resource utilization: Maximize return on investment, and a clear path towards bringing breakthrough drugs to market faster. Our solutions have helped provide intuitive indicators for resource management, giving resource managers full control over utilization metrices.\n\nCollaboration: Planisware\u2019s PEX reporting feature fosters a collaborative environment where your team can thrive. Real-time dashboards provide complete transparency into project progress and resource utilization. This empowers team members to hold each other accountable, identify potential roadblocks early on, and stay laser-focused on shared goals. Our solution also facilitates knowledge sharing across teams, ensuring everyone has the information they need to drive innovation forward.\n\nBy establishing Planisware as a centralized command centre for resource planning, you can maximize workforce agility, balance workloads, accelerate throughput, and drive higher ROI from your existing Planisware investments.\n\nRead more about our resource management case study here.\n\nOneFolio\n\nOneFolio is a centralized platform that connects your portfolio and resource tracking data and presents insights through interactive visualizations and real-time dashboards. OneFolio\u2019s capabilities allow you to integrate data from your PPM tool (project schedules, resource needs) and HR system (employee skills, timesheets), and consolidate it into a single, intuitive platform. You can view global and local resource availability mapped to various product portfolios. Quickly identify upcoming resource gaps/spikes, skills gaps, growth needs, outsourcing requirements, and other constraints.\n\nOneFolio\u2019s advanced scheduling algorithms enable dynamic scenario modeling to evaluate resource allocation trade-offs across any combination of portfolios, pipelines, and therapeutic areas, enabling you to proactively plan for shifting uncertainties and risk factors.\n\nHow OneFolio can help you?\n\nBetter resourcing decisions: OneFolio acts as a central hub, eliminating manual data entry and ensuring complete transparency into project progress, personnel activity, and resource allocation. This unified data landscape empowers you to make informed decisions about talent deployment and project prioritization.\n\nTransparency: Our integrated activity tracker highlights on the daily tasks and activities involved in each project. By leveraging data from your HR system (timesheets/activities), you gain granular insights into project progress and resource utilization. This allows you to identify potential roadblocks early on, track progress against timelines, and ensure everyone is aligned with project goals. Real-time activity data also facilitates better time management for team members, optimizing their focus on high-impact tasks.", "start_char_idx": 0, "end_char_idx": 5562, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "adbc07a9-1ca8-4e10-8654-065ab0564cbd": {"__data__": {"id_": "adbc07a9-1ca8-4e10-8654-065ab0564cbd", "embedding": null, "metadata": {"file_name": "Resource management.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Resource management.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25740, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "00501aa2-e3bc-4bc5-a0f8-2514db95ae56", "node_type": "4", "metadata": {"file_name": "Resource management.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Resource management.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25740, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "f91cde520f3e90bc1e38a202c24606f0a400f08940a5cbad0ae440efa16af779", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ee2dd707-7e3f-4ff9-9158-9a34edf52264", "node_type": "1", "metadata": {"file_name": "Resource management.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Resource management.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25740, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "4a4bc55df8ed468cbda28796c913f3838ef425f5dab0e57fe7c1c9b5e1b412eb", "class_name": "RelatedNodeInfo"}}, "text": "Transparency: Our integrated activity tracker highlights on the daily tasks and activities involved in each project. By leveraging data from your HR system (timesheets/activities), you gain granular insights into project progress and resource utilization. This allows you to identify potential roadblocks early on, track progress against timelines, and ensure everyone is aligned with project goals. Real-time activity data also facilitates better time management for team members, optimizing their focus on high-impact tasks.\n\nReal time insights: Dynamic dashboards provide a real-time view of project health, resource allocation, and activity status. With these insights at your fingertips, you can proactively address any resource bottlenecks or project deviations. The ability to make data-driven adjustments and optimize workflows leads to improved project timelines, reduced costs, and ultimately, accelerated delivery of life-saving treatments.\n\nSmarter allocations: Beyond data unification, our offering leverages powerful algorithms to match the right talent with the right task at the right time. By considering resource skillsets, project needs, and current workload, it recommends optimal resource allocation strategies. This data-driven approach ensures that critical projects are staffed with the most qualified personnel, fostering efficient utilization of resources, and maximizing project success rates.\n\n\n\nRead more about our OneFolio implementation in a Big Pharma here <insert link>\n\n\n\n\n\n\n\nReporting bundle [Merck Dashboards]\n\n-Effective resource management requires seamless visibility across all aspects of planning, execution, and actuals. However, fragmented data in disconnected tools and systems obscures this view, leading to inaccurate forecasting and suboptimal resource utilization.\n\nOur integrated reporting bundle solves this by consolidating and harmonizing resource data from your PPM solution and enterprise timesheets into a centralized reporting fabric. This provides a \"single source of truth\" for complete resource insights spanning forecasted, scheduled, and actual work.\n\nAt the core is a robust data integration layer connecting your project management tools like Planisware to timesheet platforms using APIs and web services. Automated ETL pipelines flow resource assignment data, task estimates, and schedule plans from the PPM system.\n\nThis information is intelligently mapped to timesheet entries capturing actuals like hours logged per task, earned value metrics, downtime and more. Customizable roll-up structures and data models align with your specific operational hierarchies.\n\nThe integrated data repository feeds a portfolio of pre-built reports, dashboards, and analytics tailored for different resource management personas - from workforce managers to financial controllers and executive leadership.\n\nInteractive visualizations provide unified visibility into resource demand vs supply, forecasted vs actual expenditure, project burdens, profitability metrics and more. Drill into root-cause analysis of deviations between planned effort and actuals.\n\nHow can you leverage i2e\u2019s reporting bundle?\n\nCustomizations: This is a tool agnostic offering, whether you use Planisware or any other PPM tool, we can create a customized dashboard on Spotfire, Tableau or Power BI, helping you drive resource accountability. AI-assisted variance decomposition and anomaly detection rapidly surfaces underutilized resources, skills shortages, projects at risk and other areas requiring attention. Automated alerts and notifications drive timely intervention.\n\nTransparency: Our flexible self-service reporting solution and data blending empower advanced ad-hoc analysis without ongoing IT/BI team dependency.\n\nBetter decision making: With a seamless integration of PPM and timesheet data, resource managers finally gain multidimensional insights to optimize resource usage, control costs, enhance productivity and ensure strategic execution across portfolios.\n\nRead more about our implementation of customized reporting bundles in Big Pharma here. <insert link>", "start_char_idx": 5036, "end_char_idx": 9138, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "0b7d9814-b190-42cc-acbf-f2c6d5be4faa": {"__data__": {"id_": "0b7d9814-b190-42cc-acbf-f2c6d5be4faa", "embedding": null, "metadata": {"file_name": "Solution - Business Development and Licensing.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solution - Business Development and Licensing.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 30429, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "dd82ef3b-362f-429f-94ed-78b4d02e9b73", "node_type": "4", "metadata": {"file_name": "Solution - Business Development and Licensing.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solution - Business Development and Licensing.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 30429, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "f85d0e6381ddc02274955320324b1668954fc668e63999dbc1c17ff2b3cd1b68", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9e33f263-73be-440b-b69e-dda9e9f51fb1", "node_type": "1", "metadata": {}, "hash": "912ebc453858c0d12f43bcf15bf3abcd0662783e4d2963f9163ea7f57d43a94a", "class_name": "RelatedNodeInfo"}}, "text": "Business development and licensing\n\nIndication and Asset Prioritization\t\n\nForecasting and Valuation\n\nTarget Product Profile (TPP) & Partnering Package Preparation\n\nPartner Identification and reach out\n\nBD/Licensing\n\nStrapline: Powering partnerships with data-driven deal insights.\n\ni2e\u2019s BD & Licensing (BD&L) offerings help BD&L decision makers take the right decisions right from evaluating high-value licensing opportunities to identifying potential acquisition targets, conducting business and product due diligence.\n\nLeveraging real-world data and predictive modeling, we quantify unmet needs to highlight indications with significant commercial potential. We forecast peak sales, develop pricing scenarios, and assess competitive dynamics to value assets and enhance deal structuring.\n\nTo articulate asset value, our analytics inform the development of compelling target product profiles and partnering materials, quantifying clinical differentiation and strategic market fit.\n\nWe identify optimal partners through proprietary company matching algorithms and payer/KOL sentiment analysis. Our data quantifies potential synergy based on portfolio fit, risk tolerance, and capabilities. Prioritized outreach is enabled through target company briefings with clinical, commercial, and deal rationale insights.\n\nWith our end-to-end solutions approach, BD teams can focus efforts on high-potential indications, assets, and partners to enhance pipeline expansion. We turn real-world evidence into actionable data to support evaluation, forecasting, packaging, outreach, and negotiations.\n\nIndication and Asset Prioritization\n\nStrapline: Strategic prioritization for high-value opportunities\n\nThe ability to separate the most promising prospects from other less favourable ones is a key competitive edge. i2e helps align asset prioritization with core organizational capabilities, organizational risk tolerance, alignment with complimentary assets, guided by optimizing for higher probability of success. \n\nWe enable BD&L teams to identify, evaluate, and prioritize the most promising indications and assets to license or acquire. \n\nPrioritization: Identification of high-lifecycle value candidates, analysis of clinical and commercial viability through meta analysis, modeling, and simulation. Our approach quantifies potential value considering development costs, regulatory risks, reimbursement exposure, and competitive landscape evolution.\n\nPositioning: We help you develop and communicate compelling clinical differentiation and commercial analytics to maximize deal value. Our domain experts and proprietary algorithms also inform target pricing scenarios and design of value-based contracts.\n\nSelection: BD teams can zero in on the right indications and assets to expand pipelines and portfolios. We turn real-world evidence into actionable insights, forecasts, and risk analyses that objectively prioritize opportunities. This enhances deal sourcing and evaluation while optimizing capital allocation.\n\n\n\nForecasting and valuation\n\nStrapline: Navigating deals with precision forecasting and valuation.\n\nBD&L teams need to accurately value assets and forecast potential returns to strengthen their negotiating positions and improve chances of deal-making success. Our solutions leverage real-world data, predictive analytics, and financial modeling to provide data-driven forecasts and valuations.\n\nWe quantify addressable patient populations and market access dynamics to forecast peak year sales and revenue potential for pipeline assets or external opportunities. Our models factor in competitive forces, clinical meaningfulness, payer coverage, and other variables to build validated projections. Scenario analysis identifies upside and downside risks to inform risk-adjusted valuations.\n\nEquipped with our quantified forecasts and valuations, BD&L teams can optimize deal structuring with milestones, royalties, and other terms aligned to asset value. We provide actionable insights into pricing scenarios, growth factors, and exclusivity benefits to inform decision making. Ongoing tracking helps monitor asset performance post-deal.\n\nOpportunity Sizing: Leveraging real-world epidemiology data, clinical guidelines, and treatment trends, we accurately quantify addressable patient populations to establish the revenue potential associated with pipeline assets or external opportunities. Our detailed opportunity sizing analysis provides a strategic perspective on peak market size.\n\nForecasting Models: We build customized predictive models leveraging advanced analytics to forecast product uptake, adoption curves, peak year sales, and long-term projections. Our forecasting helps to quantify revenue potential based on competitive dynamics, market access, differentiating features, and other variables.\n\nScenario Analysis: We conduct scenario analyses to stress test key assumptions and provide risk-adjusted forecasts reflecting a range of outcomes. By quantifying upside potential and downside risks, we provide BD&L teams with the full spectrum of possibilities to inform valuation.\n\nValuation Advisory: Based on our opportunity sizing, forecast models, and scenario planning, we derive data-driven valuations reflecting real-world potential. We advise on optimal deal structures and terms such as milestones, royalty rates, and exclusivity considerations to maximize asset value.", "start_char_idx": 0, "end_char_idx": 5398, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "9e33f263-73be-440b-b69e-dda9e9f51fb1": {"__data__": {"id_": "9e33f263-73be-440b-b69e-dda9e9f51fb1", "embedding": null, "metadata": {"file_name": "Solution - Business Development and Licensing.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solution - Business Development and Licensing.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 30429, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "dd82ef3b-362f-429f-94ed-78b4d02e9b73", "node_type": "4", "metadata": {"file_name": "Solution - Business Development and Licensing.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solution - Business Development and Licensing.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 30429, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "f85d0e6381ddc02274955320324b1668954fc668e63999dbc1c17ff2b3cd1b68", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0b7d9814-b190-42cc-acbf-f2c6d5be4faa", "node_type": "1", "metadata": {"file_name": "Solution - Business Development and Licensing.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solution - Business Development and Licensing.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 30429, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "77ada0dba0f92e009567585ecc710d7799e5de85dfb3a23fcc4555aaa0705edc", "class_name": "RelatedNodeInfo"}}, "text": "By quantifying upside potential and downside risks, we provide BD&L teams with the full spectrum of possibilities to inform valuation.\n\nValuation Advisory: Based on our opportunity sizing, forecast models, and scenario planning, we derive data-driven valuations reflecting real-world potential. We advise on optimal deal structures and terms such as milestones, royalty rates, and exclusivity considerations to maximize asset value.\n\nTarget Product Profile (TPP) & Partnering Package Preparation\n\nStrapline: Positioning you for deal success\n\nAn integrated and cross-functionally developed Target Product Profile (TPP) facilitates strategic product go/no-go decision making along the development pathway at the different stage gates, minimizes risk, and improves contingency planning.\u00a0Our TPP offering enables business development teams to optimize TPPs to articulate clinical value, enhance asset positioning, and align to strategic needs.\n\nEvaluation: Leveraging real-world data on disease burden, treatment dynamics, and unmet needs, we identify differentiated clinical endpoints and study designs to highlight your asset\u2019s advantages. Analyzing prescriber, patient, and payer perspectives, we define a minimum viable product profile and commercial recommendations to convey market attractiveness.\n\nPreparation: Modeling and forecasting of the competitive landscape informs required features to support favorable access and adoption. By quantifying the incremental value of potential indications, we advise expansion opportunities beyond initial targets.\n\nPresentation: With our data-driven approach to TPP development, you can precisely convey the clinical and commercial potential of assets to potential partners or acquirers. We help you to align proposed targets to corporate strategy while strengthening negotiating leverage. Our insights de-risk asset evaluation while speaking directly to stakeholder needs and constraints. Let our analytics inform compelling, optimized TPPs that position you for deal success. \n\nPartner identification and reach out\n\nStrapline: Discover strategic partnerships that accelerate growth\n\nSelecting the right partners is critical for pharma business development and licensing teams seeking to drive pipeline growth through value-creating deals. However, with multiple influencing variables externally and internally, it is challenging to identify the ideal targets with the highest strategic fit and shared value potential. Accelerated deadlines further complicate partner prioritization before outreach.\n\nPartnerships founded on robust target evaluation and strategic alignment far outperform those without. Deals with incompatible partners face higher risks of delayed milestones, disputes over rights, and other obstacles that diminish return on investment. Prioritizing partners with complementary portfolios and capabilities, as well as organizational alignment on issues like risk appetite and valuation, sets up collaborations for mutual success.\n\nGiven limited resources, BD&L teams must optimize their partner targeting to engage the prospects with the greatest likelihood of deal completion on favorable terms. By leveraging data-driven solutions to systematically identify and profile potential partners, life sciences organizations can enhance alignment, efficiency, and returns across their deal-making activities.\n\nIdentification: Drive partner identification and strategic outreach through efforts mapped to pipeline expansion. Leverage real-world data and predictive analytics to prioritize the most promising targets with strong portfolio fit, organizational alignment, and mutual value potential.\n\nOutreach: Proprietary algorithms and statistical models profile prospective partners based on deal history, risk tolerance, motivations, and other factors to inform tailored messaging. We develop data-driven target company briefings that resonate with specific partner needs and constraints, conveying the clinical, commercial, and strategic rationale for partnership.\n\nEngagement: Ongoing tracking of engagement levels and sentiment analysis enables agile follow-up and negotiations. With our specialized support, BD&L teams can focus efforts on the highest potential partners, armed with data-driven insights to communicate shared value and advance discussions.\n\nWe empower focused partnership outreach and tailored engagement using real-world evidence and analytics. Our solutions enhance deal sourcing, evaluation, and strategic relationship-building to fuel long-term pipeline growth through value-creating collaborations.", "start_char_idx": 4966, "end_char_idx": 9548, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "ab53c038-da4a-4daf-b8a6-6220997dcf4b": {"__data__": {"id_": "ab53c038-da4a-4daf-b8a6-6220997dcf4b", "embedding": null, "metadata": {"file_name": "Solution - Commercial.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solution - Commercial.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 32118, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "44689381-06a7-41a8-b39b-b7f61185ffaf", "node_type": "4", "metadata": {"file_name": "Solution - Commercial.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solution - Commercial.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 32118, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "f8128d7c90f250485c849b456799e7f1903234561671b7be50b66eab72a63f3a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6465504f-dbd4-41ab-a25c-993a46b966af", "node_type": "1", "metadata": {}, "hash": "a48ff0f931e10d29b99a9b3e2142dace2a4cb026613c1c456dfdaafc88003261", "class_name": "RelatedNodeInfo"}}, "text": "Commercial\n\nForecasting and valuation\n\nBI dashboards\n\nMarketing and digital services\n\nSales analytics\n\nMarket access\n\nCommercial\n\nStrapline: Unlocking commercial success with data-driven insights.\n\nForecasting\n\nStrapline: Align R&D portfolio investments with commercial outcomes\n\nPharma R&D executives require real-time visibility into pipeline health. Our proprietary forecasting solution offers an intuitive and comprehensive view of the full pipeline, enabling R&D decision makers to monitor project progress, resource allocation, and financial performance in a single, user-friendly interface.\n\nThe dashboards are customizable, allowing executives to tailor views based on their specific needs. From pipeline analysis and portfolio performance to resource utilization and risk assessment, our solution provides a 360-degree perspective on R&D operations. This not only streamlines decision-making but also fosters collaboration and transparency across globally distributed R&D teams.\n\nOur forecasting solution is built on the foundation of advanced predictive analytics, providing R&D executives with the tools needed to anticipate trends, mitigate risks, and optimize decision-making. By leveraging machine learning algorithms and predictive modeling, our platform analyzes vast datasets, extracting valuable patterns and insights that empower executives to make informed choices at every stage of drug development.\n\nThe forecasting module goes beyond traditional methods, incorporating real-world evidence, clinical trial data, and market trends. This holistic approach not only enhances the accuracy of predictions but also enables proactive decision-making, allowing R&D teams to pivot strategies swiftly based on evolving market dynamics.\n\nEnhanced decision making: Empower the team with consolidated data to monitor and evaluate project performance and development scenarios. Automated data aggregation & report generation saves valuable time to focus on strategic initiatives.\n\nAdvanced risk management: Receive timely alerts and access project-level details to proactively mitigate risks and their impact on the portfolio. Foster a culture of accountability and transparency where all portfolio stakeholders have access to real-time project data to better manage their contributions.\n\nScalability and future readiness: Easily scale and evolve dashboard features and prediction capabilities as your organization increases alignment and expands the use of decision dashboards.\n\n\n\n\n\n\n\nBI dashboards\n\nStrapline: Actionable analytics for strategic commercial decisions.\n\nWe help you transform siloed organizational data into strategic insights through business intelligence dashboards. We leverage statistical modelling and machine learning to help you uncover intelligence beyond surface-level metrics. Executives can track KPIs like campaign ROI, pipeline health, and forecast accuracy over time. Custom filters allow you to analyze data and distil insights by region, brand, team, and product segments.\n\nWith our BI dashboards, you can detect early warning signs, optimize resource allocation, forecast more accurately, and respond quickly to market changes. Our flexible delivery models allow you to leverage BI either as a managed service or self-service software. \n\nWe understand that regular dashboards may not be able to meet the requirements of a large, globally distributed team, hence we have flexibility and customization built into our offering. We help your teams go beyond basic metrics by leveraging statistical modeling, predictive analytics, and machine learning algorithms to surface key trends, relationships and opportunities hidden within your data. Users can easily filter and segment KPIs by business unit, product, region, customer type and more to gain targeted insights that inform strategic planning.\n\nIntelligence: Empower your commercial teams by providing them with vital insights to drive decision making. Robust permissions and access controls ensure alignment to your business needs and compliance standards.\n\nInsights: Get actionable insights for any metric at a click, be it performance vs targets for revenues, market share, or messaging effectiveness. Isolate and diagnose root causes to drive remedial actions. Access analytics that empower your teams make data-driven decisions on-the-go.\n\nImpact: You get operational visibility across your commercial operations through visually intuitive, interactive dashboards. KPIs can be monitored in real-time across dimensions like products, HCP engagement, and sales channels.", "start_char_idx": 0, "end_char_idx": 4565, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "6465504f-dbd4-41ab-a25c-993a46b966af": {"__data__": {"id_": "6465504f-dbd4-41ab-a25c-993a46b966af", "embedding": null, "metadata": {"file_name": "Solution - Commercial.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solution - Commercial.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 32118, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "44689381-06a7-41a8-b39b-b7f61185ffaf", "node_type": "4", "metadata": {"file_name": "Solution - Commercial.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solution - Commercial.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 32118, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "f8128d7c90f250485c849b456799e7f1903234561671b7be50b66eab72a63f3a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ab53c038-da4a-4daf-b8a6-6220997dcf4b", "node_type": "1", "metadata": {"file_name": "Solution - Commercial.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solution - Commercial.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 32118, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "3edf9c377cf3f3ac83969362a2b0ba433e3040e074a6048f5af465bc26d1e50d", "class_name": "RelatedNodeInfo"}}, "text": "Marketing and digital services\n\nStrapline: Drive performance with data-driven marketing intelligence.\n\nMarketing teams are struggling to drive brand preference, engagement, and revenue alignment. Our marketing and digital services helps you optimize your marketing mix, messaging resonance, HCP engagement. We leverage your existing data generate actionable strategies addressing the unique challenges in clinical, regulatory, and access dynamics, helping you create marketing programs that are globally compliant and locally relevant.\n\nWhether it is about building cohesive messaging platforms powered by patient insights or developing an analytics dashboards tracking HCP targeting, our solutions are designed to support agile decision making. Our augmented intelligence tools guide you for developing content, personalization, attribution and engagement across the entire lifecycle.\n\nMarket research: Leverage audience intelligence and discovery (HCP and patient), channel modelling and execution to power the right strategy using our AI-led market research services.\n\nMarket and channel strategy: Choose the right elements in the promotional mix to drive revenue,\u00a0align internal teams, and\u00a0gain market traction. Our statistical models help you optimize your campaigns to find the right channel mix, creative personalization, and monitor spend allocation.\n\nCampaigns and monitoring: Create multiple digital touchpoints based on audience data, powered by intelligent targeting and personalization.\n\nEngagement and experience: Use analytics, expertise, and insights to drive more productive physician engagement programs, CME interventions.\n\nMarket access\n\nStrapline 1: Unlocking market access with real-world evidence and insights.\n\nTherapy launch success is built on the backbone of a robust market access strategy. Market access teams face increasing pressures from government, HCPs, medical associations, patient groups while having to negotiate heterogenous regulatory and reimbursement pathways, managing payer and providers expectations, driving partnership arrangements and contracts.\n\nOur market access solutions help you drive more effective product launches, with recommendations for pricing, contracting, and reimbursement strategies built in with real-world data and analytics. We help you build evidence from claims data, EMR records, and specialty datasets linking your therapy to improved health outcomes and cost savings.\n\nWe help you quantify the budget impact and develop clinical value proposition to drive successful payer negotiations. Our market modeling and forecasting services help project population disease burden, treatment dynamics, and estimated budgetary impact for various scenarios. Our advanced analytics and modelling frameworks help you identify optimal pricing scenarios, predict regional formulary access, and develop messaging that resonates with payers. You can assess competitive landscape and advise on contracting tactics and channel mix to maximize market share. Our post-launch services include support for tracking prescription trends, treatment adherence, and real-world outcomes to support continued access and positive reimbursement.\n\nMarket access strategy: We help you drive your market access strategy\u00a0from clinical development to post-patent expiry across diverse disease areas, market characteristics, regulatory guidelines. Whether it is payer contracting, developing a patient support strategy or healthcare policy impact assessments, our market access program helps you communicate therapy value to all stakeholders with data, expertise and technology.\n\nValue Development: Create a compelling therapy value proposition, leveraging evidence generation planning, market intelligence to create comprehensive evidence roadmaps. \n\nOptimization: Leverage i2e\u2019s proprietary methodology and domain expertise to answer what-if scenarios. Shorten time-to-analysis by modelling critical market access questions that determine gross-to-net conversion. Analyse impact of complex contract and pricing\u00a0changes in days, not months.\n\nDecision support: Right from driving effective negotiations with payers and providers, developing an overarching pricing architecture, to product specific pricing strategy, leverage our decision support to drive consensus on cost impact and benefits between regional offices and country systems.\n\nSales analytics\n\nTagline: Drive sales excellence by connecting data, analytics and expertise \n\nOur sales analytics solution improves sales RoI by helping you create a sales analytics center-of-excellence. Right from strategy to reporting optimization, our sales analytics solution helps drive performance, benchmarking, forecasting to identify growth opportunities. We analyse data from multiple source points, field activities, industry/market trends, sales drivers, and opportunities to enable sales decision makers decide resource allocation, field force sizing, territory alignment, incentive strategies and recommendations for optimizing RoI. With seamless CRM integration, user-friendly dashboards, and a dedicated analytics team, we help you drive sales excellence.\n\nStrategy: Drive capital budgeting and investments and track RoI from omnichannel sales. Forecast brand performance, track promotions strategy and HCP engagement.\n\nSales Intelligence: Analyse factors influencing prescription behaviour, anomaly detection, threshold-based alerts. Increase KOL alignment with predictive intelligence by analysing KOL behaviour.\n\nOperational excellence: Drive call plans, field insights, call plan adoption, customized outreach cadences for HCPs.\n\nInsights: Actionable sales insights to understand prescription behavior, drive custom messaging, and drive brand performance.", "start_char_idx": 4569, "end_char_idx": 10318, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "933f05dd-5c86-444a-a415-b90187bfc346": {"__data__": {"id_": "933f05dd-5c86-444a-a415-b90187bfc346", "embedding": null, "metadata": {"file_name": "Solutions - Business Research.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solutions - Business Research.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25208, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "80d027b1-4e89-4290-92b5-5cd5bc479f0f", "node_type": "4", "metadata": {"file_name": "Solutions - Business Research.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solutions - Business Research.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25208, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "221f7494d55116da6adb0fc4b47d404b3acf24277d811fa248748439dc1b863d", "class_name": "RelatedNodeInfo"}}, "text": "Business Research\n\nStrapline: Better evidence for faster decision making\n\nLife sciences organizations have historically not been at par with their industry peers for digital maturity. With data coming in from sources as disparate as field communications, to contact centers, to payer observations, to research databases, there is an immense need to not just structure but transform data for a strategic advantage.\n\nOur business research services help you in using data to build your digital moat, whether it is in competitive intelligence or develop novel market access strategies.\n\nCompetitive Intelligence\n\nStrapline: Creating limitless possibilities with insights\n\ni2e\u2019s competitive intelligence suite is a rapid deployment solution to equip your competitive intelligence team with valuable insights from your recommended databases and industry specific public domains.\n\nOur CI solution is a powerful tool that empowers R&D executives with real-time insights into the competitive landscape. Access to breakthrough information can help executives like you influence company strategy. Our platform leverages advanced data analytics, machine learning, and natural language processing to gather, analyze, and distil vast amounts of information from diverse sources, providing a real-time and dynamic view of the market.\n\nComprehensive competitor analysis: Through our real-time centric analysis, you can stay informed about the latest activities, developments, and milestones of key competitors. This will enable you to have a full view of the scientific landscape, right from identifying potential collaborators, partnerships, and to staying updated with emerging trends.\n\nPipeline and Product Insights: Pulse provides a detailed pipeline analysis helping you stay ahead of potential threats and opportunities. You can use Pulse to assess the success and market performance of competitor products, enabling strategic decision-making, ahead of others.\n\nRegulatory and Market Access Intelligence: Stay current with our Regulatory Landscape Monitoring feature, apprising you of regulatory changes and approvals affecting competitors.\n\nMarket Access Trends: Understand the evolving market access landscape to inform pricing and reimbursement strategies.\n\nCollaboration and Integration: Integrate CI insights from Pulse with existing R&D workflows for streamlined decision-making.\n\nCollaboration Tools: Facilitate collaboration among cross-functional teams by providing a centralized platform for sharing intelligence.\n\nMarket Assessment\n\nStrapline: Optimizing access and reimbursement with real-world evidence.\n\nWhether it is a small biopharma organization evaluating their drug commercialization strategy for their first therapy, or a Big Pharma organization optimizing their market access for emerging markets, i2e\u2019s market access solutions have helped drive effective market access deployment.\u00a0\n\nWe help you manage and communicate value in both conventional and evolving models of care, prioritizing stakeholder engagement to drive brand success.\n\nThe right market access strategy empowers successful commercialization. With variables such as complex benefits and utilization management practices, payer-side consolidation, managing multiple stakeholders such as payers, clinicians, technical experts, and HTAs, market access has been a challenging area. We help you identify challenges, anticipate risks early in the development process and throughout the product life cycle.\n\nAn effective market access strategy helps a drug deliver on its true promise and shape the future of the therapy area in the crucial years post launch. Good market access governance ensures trust building amongst key stakeholders right from providers to patients. Here is how we help you drive multi party trust, strategy engagement and therapy value.\n\nRegulatory: Our solutions help market access decision makers in driving timely marketing authorizations by utilizing local medical share-of-voice. Incorporate clinical, economic, and analytical evidence for demonstrating therapeutic value in a real-world setting.\n\nPricing and reimbursement: We help launch teams reduce reimbursement rejections through appropriate pricing and reimbursement simulation modelling with our custom reimbursement solutions. We enable you to secure localized pricing information and inclusion in reimbursement lists by incorporating local evidence considerations related to coverage and reimbursement, enabling you to leverage insights to drive successful interventions and negotiations. \n\nInfrastructure: We help you identify bottlenecks in healthcare infrastructure and overcome challenges through initiatives such as continuing medical education interventions for underrepresented specialities in your target markets.", "start_char_idx": 0, "end_char_idx": 4778, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "bfc1bccd-b193-4da5-83a6-0bc7adf74b42": {"__data__": {"id_": "bfc1bccd-b193-4da5-83a6-0bc7adf74b42", "embedding": null, "metadata": {"file_name": "Straplines.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Straplines.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 28365, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "790ac20b-1cac-4e60-aed0-10b7a37f3ab2", "node_type": "4", "metadata": {"file_name": "Straplines.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Straplines.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 28365, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "9ec4180eb9884336ac1c999f1901164238a6c3d95dc23ba0e81440eaf523adce", "class_name": "RelatedNodeInfo"}}, "text": "Offering\n\nSub-offering\n\nStrapline 1\n\nStrapline 2\n\nStrategy and consulting\n\n\n\nHelping you maximize value from investments, innovation, and insights\n\nDriving alignment between science and business\n\n\n\nStrategic portfolio management\n\nFrom pipeline growth to topline growth\n\nStrategic precision for scientific innovation\n\n\n\nR&D portfolio management\n\nFrom ambiguity to clinical certainty\n\nPrioritizing R&D investments with insights\n\n\n\nPortfolio decision analytics\n\nAligning portfolio value with organizational value\n\nFrom insights to impact\n\n\n\nMedical affairs\n\nGet evidence, analytics and insights to drive medical organization excellence\n\nInnovate with impact in mind.\n\nBusiness Research\n\n\n\nBetter evidence for faster decision making\n\nPrecision, insight, and excellence.\n\n\n\nCompetitive intelligence\n\nCreating limitless possibilities with insights\n\n\n\nBe better informed\n\n\n\nEarly warning systems\n\nBuild resilience and preparedness\n\nAnticipate, adapt and thrive.\n\n\n\nMarket assessment\n\nOptimizing access and reimbursement with real-world evidence.\n\nNavigate market access with confidence\n\nBusiness Development and Licensing\n\n\n\nPowering partnerships with data-driven deal insights.\n\nAccelerate alliances, growth, opportunities.\n\n\n\nIndication and Asset Prioritization\n\nStrategic prioritization for high-value opportunities\n\nAccelerating success through smart prioritization\n\n\n\nTarget Product Profile (TPP) & Partnering Package Preparation\n\nUnlock asset potential and convey differentiation through analytics-powered TPPs.\n\nPositioning you for deal success\n\n\n\nForecasting and valuation\n\nNavigating deals with precision forecasting and valuation.\n\nDrive forecast excellence and valuation accuracy.\n\n\n\nPartner Identification and reach out\n\nDiscover strategic partnerships that accelerate growth\n\nTargeting partnerships with data-driven insights and engagement.\n\nCommercial\n\n\n\nUnlocking commercial success with data-driven insights.\n\nStrengthen efficiency, drive compliance, streamline experiences.\n\n\n\nForecasting and valuation\n\nAlign R&D portfolio investments with commercial outcomes\n\nFrom insights to impact\n\n\n\nBI dashboards\n\nActionable analytics for strategic commercial decisions\n\nDo more with less data.\n\n\n\nMarketing and digital services\n\nDrive performance with data-driven marketing intelligence.\n\nAmplify impact with data, intelligence and insights.\n\n\n\nSales analytics\n\nDrive sales excellence by connecting data, analytics and expertise \n\nPrecision strategies for pipeline growth\n\n\n\nMarket access\n\nUnlocking market access with real-world evidence and insights.\n\nDrive market access excellence through insights and intelligence.", "start_char_idx": 0, "end_char_idx": 2620, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "63f67500-3c72-4de5-9535-f3db1698b72f": {"__data__": {"id_": "63f67500-3c72-4de5-9535-f3db1698b72f", "embedding": null, "metadata": {"file_name": "Where are you in your Planisware journey.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Where are you in your Planisware journey.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 37359, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "4844296c-c520-442e-83e1-03e996168065", "node_type": "4", "metadata": {"file_name": "Where are you in your Planisware journey.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Where are you in your Planisware journey.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 37359, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "070a0363f3d1441c57442ac3961166df69fff57c0fc2f4dbef7912061c553969", "class_name": "RelatedNodeInfo"}}, "text": "Planisware Partnership Services\n\nWhere are you in your Planisware journey?\n\n<Explore our services>\n\n\n\n         Whether you're just beginning to explore Planisware or seeking to maximize its benefits\n\n                                  i2e Consulting \u2013 a trusted Planisware partner \u2013 is here for you\n\n\n\nOur Services\n\n\n\nEvaluation\n\nOur consultants will work closely with key stakeholders to conduct a thorough audit of your existing processes to determine which tool aligns best with your business goals. Our team will also assist in technical evaluation of vendors to understand the best fit.\n\nBased on the evaluations, our consultants will develop an implementation roadmap to deliver functionalities in a way to maximize the value of the tool, while minimizing implementation risks.\n\nImplementation\n\nWe seamlessly align with other vendors and Planisware\u2019s professional services \u2013 i2e becomes part of your team. Our team is well-versed in business process needs, industry best practices, and Planisware technicalities. From implementation to user training.\n\nOur experts successfully implemented out-of-the-box features or \u201cLevel 1\u201d custom configuration with their business logic, design and data model. Our modus operandi is zero issues / zero regressions. We also cater to non-functional requirements such as data transformation, data migration, and integration with other toolsets.\n\n Scaling up\n\nFrom tailoring modules to your business needs, to integrating with external systems, we ensure that Planisware aligns seamlessly with your business processes. \n\nAdding more modules within Planisware to improve your workflows\n\nTaking advantage of new feature after a recent upgrade\n\nMaking sure Planisware remains fit for purpose after reorganizations\n\nAutomation of repetitive tasks increase end-user productivity and reduce manual errors\n\nWe can be your partner in improving data quality, building data integrity processes and supporting configuration, and ensuring best practices are adhered to. Our experience with such projects is the output received by organizations is increased trust in the Planisware data, stakeholder buy-in and user adoption, thus overall increased value from your PPM processes.\n\nIntegration\n\nWhether you're integrating Planisware with your ERP system to synchronize financial data, connecting with CTMS for clinical alignment, or connecting it with your CRM system to streamline customer information, we'll design integrations that optimize data flow and ensure data consistency across systems.\n\nWe help global organizations achieve a seamless Planisware integration which enables access to real-time, accurate information from multiple systems.\n\nAnalytics & AI\n\nOur analytics specialists will harness the data within Planisware and transform it into actionable insights. Whether it's analyzing project performance metrics, resource utilization trends, or portfolio health indicators, we'll help you gain a deeper understanding of your data and identify opportunities for improvement.\n\nBe it executive dashboards, project status reports, or resource allocation summaries, we'll develop customized reports that provide the insights you need to effectively manage your projects and portfolios.\n\nOur AI experts are proficient in Planisware predictive analytics and can train a model to predict project outcomes such as task durations, budget forecasts, and resource utilization predictions.\n\n\n\nService management\n\nWe will take care of the technical aspects so you can focus on your core business activities.\n\nOur service management services include dedicated end-user support to address any issues, or concerns that may arise during their day-to-day use of Planisware. \n\nWe can assist with\n\nTechnical difficulties\n\nAssistance with a specific feature\n\nPerformance bottlenecks\n\nGuidance on best practices\n\nOur team can also assist in applying software updates and patches and performing routine system checks and optimizations.\n\nOur services include meticulous management of master data and overseeing data processing. For organizations utilizing on-premises servers, we offer comprehensive assistance in configuration and maintenance.\n\n\n\nCase studies carousal\n\nhttps://www.i2econsulting.com/efficient-resource-management/\n\nhttps://www.i2econsulting.com/a-multi-national-company-achieves-labor-law-compliance-in-fte-calculations-using-planisware/\n\nhttps://www.i2econsulting.com/automation-technology-leader-unlocks-planisware-capabilities-and-achieves-streamlined-resource-management/\n\nhttps://www.i2econsulting.com/an-automation-company-achieves-automated-data-synchronization-between-planisware-and-salesforce/\n\n\n\n\n\nInsights\n\n<blogs>", "start_char_idx": 0, "end_char_idx": 4656, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}, "b93ebcfa-d2c7-488e-a480-9e7a8b628627": {"__data__": {"id_": "b93ebcfa-d2c7-488e-a480-9e7a8b628627", "embedding": null, "metadata": {"file_name": "Work @i2e.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Work @i2e.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 26464, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "40d7ae4f-be1e-4932-a65a-a16b93fd20d9", "node_type": "4", "metadata": {"file_name": "Work @i2e.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Work @i2e.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 26464, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}, "hash": "178b671ccbd7d5c888f15e063eea8c7a0e5e13e4c751e9db5d5651fb9ecb9239", "class_name": "RelatedNodeInfo"}}, "text": "Work@i12e\n\nDesign: Refer PPT\n\n\n\nStrapline 1: Creativity, innovation and impact: All @i2e\n\nStrapline 2: Ideas that drive innovation, execution that transforms.\n\nH1: What does working at i2e look like?\n\nGreat workplaces help people thrive. And i2e helps you thrive by enabling a people-first culture, a shared purpose, guided by values that drives our ideas to execution.\n\nWe have created a culture of excellence, where people thrive by helping bring their ideas to life. We are focused on innovation, led by experimentation, all in the quest to create amazing experiences for our customers.\n\nWe have been certified as a Great Place to Work, three times in a row. We believe that the true path to enterprise growth is through employee growth and have invested in creating employee experiences that encourage learning, development and career progression.\n\nWhy will you love working @i2e?\n\nOpportunities \n\nLearning\n\nCulture\n\nYou will work on projects that will transform industries in fundamental ways in the years to come. You will have exposure to new opportunities and will enjoy adapting to the learning curve.\n\ni2e emphasises learning and growth. There is a focus on knowledge development intra- and inter-teams. We are knowledge led and insight focused.\n\nOur culture emphasises collaboration, communication and cohesiveness. You will feel part of a community guided by our core values led by our shared beliefs on what\u2019s possible.\n\n\n\nGet to know our teams\n\nTeam 1\n\nTeam 2\n\nTeam 3\n\nHR\n\nMarketing\n\nPractice teams\n\n\n\nHear from our employees\n\nTestimonial 1\n\nTestimonial 2\n\nTestimonial 3\n\n\n\nIndustry recognition\n\nGPTW certifications\n\nExplore opportunities at i2e", "start_char_idx": 0, "end_char_idx": 1659, "text_template": "{metadata_str}\n\n{content}", "metadata_template": "{key}: {value}", "metadata_seperator": "\n", "class_name": "TextNode"}, "__type__": "1"}}, "docstore/ref_doc_info": {"59fbecda-6156-4f58-a7c7-22664ae007d6": {"node_ids": ["ca105563-483d-40fe-80f1-6f6f756a34bf"], "metadata": {"file_name": "About us page.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\About us page.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 24292, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "25cec983-7e0c-4f6e-80d7-91bc7d77de2d": {"node_ids": ["b4f9d316-86ec-4b5d-a537-19ea4959f52f"], "metadata": {"file_name": "Change Management-Planisware.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Change Management-Planisware.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 27611, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "6cf2ecc2-6aaf-474b-ac39-51d09571ba7a": {"node_ids": ["c71ad92a-e708-4900-8774-85d47de4f308", "6501bc42-c37b-4bec-be37-a8dff4869c9a"], "metadata": {"file_name": "Clairvoyance 2.0.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Clairvoyance 2.0.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 34361, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "fca7c5d1-758d-4241-89b4-eb2967a7ab39": {"node_ids": ["1658a190-c1b2-48ba-90aa-cdfce6409f0d", "81702a86-f4d2-408d-baf7-a7c685ce62cb"], "metadata": {"file_name": "Clairvoyance 3.0.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Clairvoyance 3.0.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25664, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "f7e729ac-6e8b-4149-b301-941074f48622": {"node_ids": ["cda50a1e-e7f1-440b-9c51-ed6a5acc1303"], "metadata": {"file_name": "ESG website.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\ESG website.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25588, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "b82e9f3c-09d4-4226-878f-f98c664a83c9": {"node_ids": ["260be4ec-081c-407f-9b7d-64b81fe3d8d7", "09082eeb-ed0b-4072-9e4c-8342673fee84", "c4855293-ab9e-4763-bdc9-d092b9c68e9c", "5dff48db-0ec0-46c9-837a-a535a58749a3", "9869ce23-1379-43e3-bb66-ce51ccf7d09d", "82ff1241-dd62-41b2-9748-082f33895ac3", "06bee9fa-1f69-45a2-80d0-e51596471aed", "ae6f91f4-9c2f-4427-9a28-1e6f429df9aa", "99fc276a-9d80-4b50-9d4c-f5eff661bd8f"], "metadata": {"file_name": "Gen AI content for website v2.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Gen AI content for website v2.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 94582, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "98cc6f61-4959-47d8-9b52-9d9113037a59": {"node_ids": ["2ae79675-0c62-43a3-b248-c8bfed8c7b74"], "metadata": {"file_name": "i2e\u2019s 4 phase road mapping.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\i2e\u2019s 4 phase road mapping.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 22928, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "e8b7c9e8-6645-4aec-8f45-f4dd18e35dff": {"node_ids": ["582e079c-2360-4dce-902d-e40ae4354fa1"], "metadata": {"file_name": "IT-PPM Setup.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\IT-PPM Setup.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 40482, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "8b42b374-4b68-48dd-81e2-66429f31a7e9": {"node_ids": ["1ea78891-5b04-4ee0-9725-5e2b13632947"], "metadata": {"file_name": "Offerings - Strategy & Consulting.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Offerings - Strategy & Consulting.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 26104, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "0260d65c-88d7-40f2-9dea-c7f2c0641e19": {"node_ids": ["ccadba87-d980-42f4-b921-b8d001e6f36e"], "metadata": {"file_name": "Our leadership.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Our leadership.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 236867, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "52b6b13f-0153-47f6-bf11-94cc62c72001": {"node_ids": ["58ab9838-950c-4053-914a-3e12e95d0dd4"], "metadata": {"file_name": "Partner page.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Partner page.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 29164, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "6e4fefb9-005a-4784-ae24-29ad4358f53a": {"node_ids": ["25aa0be8-6cdb-4f24-9623-91ec8ae25635"], "metadata": {"file_name": "Planisware consulting content.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Planisware consulting content.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25732, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "26c53517-9bf4-40c1-a7f0-9be5fc0cae1d": {"node_ids": ["7dacb244-2740-45bf-93d0-5dfafc75decf"], "metadata": {"file_name": "Planisware Upgrade Testing.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Planisware Upgrade Testing.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25526, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "2e6569f8-ea8b-449b-b85e-d8e3ed7a2548": {"node_ids": ["c73b6650-3a06-4b2c-83c8-0ba936298b29"], "metadata": {"file_name": "PPM Analytics- Planisware.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\PPM Analytics- Planisware.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 28173, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "00501aa2-e3bc-4bc5-a0f8-2514db95ae56": {"node_ids": ["ee2dd707-7e3f-4ff9-9158-9a34edf52264", "adbc07a9-1ca8-4e10-8654-065ab0564cbd"], "metadata": {"file_name": "Resource management.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Resource management.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25740, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "dd82ef3b-362f-429f-94ed-78b4d02e9b73": {"node_ids": ["0b7d9814-b190-42cc-acbf-f2c6d5be4faa", "9e33f263-73be-440b-b69e-dda9e9f51fb1"], "metadata": {"file_name": "Solution - Business Development and Licensing.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solution - Business Development and Licensing.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 30429, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "44689381-06a7-41a8-b39b-b7f61185ffaf": {"node_ids": ["ab53c038-da4a-4daf-b8a6-6220997dcf4b", "6465504f-dbd4-41ab-a25c-993a46b966af"], "metadata": {"file_name": "Solution - Commercial.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solution - Commercial.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 32118, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "80d027b1-4e89-4290-92b5-5cd5bc479f0f": {"node_ids": ["933f05dd-5c86-444a-a415-b90187bfc346"], "metadata": {"file_name": "Solutions - Business Research.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Solutions - Business Research.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 25208, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "790ac20b-1cac-4e60-aed0-10b7a37f3ab2": {"node_ids": ["bfc1bccd-b193-4da5-83a6-0bc7adf74b42"], "metadata": {"file_name": "Straplines.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Straplines.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 28365, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "4844296c-c520-442e-83e1-03e996168065": {"node_ids": ["63f67500-3c72-4de5-9535-f3db1698b72f"], "metadata": {"file_name": "Where are you in your Planisware journey.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Where are you in your Planisware journey.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 37359, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}, "40d7ae4f-be1e-4932-a65a-a16b93fd20d9": {"node_ids": ["b93ebcfa-d2c7-488e-a480-9e7a8b628627"], "metadata": {"file_name": "Work @i2e.docx", "file_path": "C:\\Users\\amiya.singh\\Documents\\Personal_Data\\pythonProject1\\Sample\\Work @i2e.docx", "file_type": "application/vnd.openxmlformats-officedocument.wordprocessingml.document", "file_size": 26464, "creation_date": "2024-05-09", "last_modified_date": "2024-05-09"}}}}